Steven E. Lipshultz MD

Steven Lipshultz

Steven E. Lipshultz
MD

Professor

Department of Pediatrics

Jacobs School of Medicine & Biomedical Sciences

Specialty/Research Focus

Pediatrics

Contact Information
UBMD Pediatrics
875 Ellicott Street
Suite 5018
Buffalo, New York 14203
Phone: (716) 881-7991
Fax: (716) 842-2100
slipshul@buffalo.edu
View map


Overview Research Publications Activities Latest News

Education and Training:
  • Fellowship, Cardiology, American Heart Association-Bugher Foundation Centers for Molecular Biology in the Cardiovascular System (1988)
  • Fellowship, Clinical Cardiology, Harvard Medical School (1986)
  • Residency, Pediatrics, Case Western Reserve University (1984)
  • Internship, Pediatrics, Case Western Reserve University (1982)
  • MD, Medicine, Dartmouth Medical School (1981)
  • MA, Developmental, Molecular and Cellular Biology, University of Pennsylvania (1980)
  • BA, Biology, University of Pennsylvania, Cum Laude (1976)

Employment:
  • Advisor/Reviewer, Daniel Maywalt's peer reviewed, first authored original research paper in May 2024 that was selected for an award. Mr. Maywalt is an author on 3 review articles/book chapters. Mr. Maywalt presented the results of his University at Buffalo Medical Student summer research with Dr. Lipshultz in February 2024 at the annual research symposium for medical students. (2024-present)
  • Chair, External Advisory Committee, NIH Centers of Biomedical Research Excellence (COBRE-Diabetes) grant from the National Institute of General Medical Sciences renewal on Diabetes and Metabolic Diseases (2024-present)
  • Chief Medical Officer, Medical Advisor Board, Children's Cardiomyopathy Foundation (2024-present)
  • Co-investigator, NIH RO1 on “Elucidating the Genetic Susceptibility to Anthracycline Cardiotoxicity (2024-present)
  • Consultant, NIH - Cardiac muscle LIM protein (MLP)-related cardiomyopathies (2024-present)
  • Consultant, Rocket Pharma (2024-present)
  • Developer, Leader and Mentor of Senior Scholar Program in Pediatric Cardiomyopathy, Children’s Cardiomyopathy Foundation and the Kyle John Foundation (2024-present)
  • Editor-in-Chief, Cardio-Oncology (2024-present)
  • Editor-in-Chief, Progress in Pediatric Cardiology. Elsevier (2024-present)
  • Investigator, Children’s Cardiomyopathy Foundation Research Grant Application (2024-present)
  • Invited to continue to be Member of the External Advisory Board, St. Jude Lifetime Cohort (SJLIFE) Study (2024-present)
  • Medical Director, Children’s Cardiomyopathy Foundation Webinar Series and Library (2024-present)
  • Medical Director, Sofia’s Hope Webinar Series and Library (2024-present)
  • Principal Investigator, Children’s Cardiomyopathy Foundation Research Grant Proposal (2024-present)
  • Principal Investigator, Organizer, Chair, Planning Committee, and Chair, Steering Committee, Sixth International Conference on Pediatric Cardiomyopathy (2024-present)
  • Private Investigator, NHLBI resubmission RO1 grant application (HL175998) (2024-present)
  • Reviewer, Children’s Cancer and Leukaemia Group (CCLG) and The Little Princess Trust (LPT) Grant Program to support research into childhood cancers (2024-present)
  • Reviewer, JNCCN-Journal of the National Comprehensive Cancer Network (2024-present)
  • Reviewer, Journal of Clinical Medicine (2024-present)
  • Reviewer, Journal of Human Hypertension (2024-present)
  • Reviewer, Nature Reviews Cardiology (2024-present)
  • Reviewer, Nutrition (2024-present)
  • Reviewer, The Lancet Rheumatology (2024-present)
  • Reviewer, UK Research and Innovation Funding Service-MRC Pre doctoral clinical research training fellowship (CTRF) (2024-present)
  • Stakeholder Reviewer, Clinical Practice Guideline of the National Cancer Institute Children’s Oncology Group Supportive Care Committee (2024-present)
  • Director, Pediatrics, Heart University, International Cardio-Oncology Society, and Webinar Series (2020-present)
  • Professor of Pediatrics, Department of Pediatrics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences (2018-present)
  • Professor of Pediatrics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences Clinical and Translational Research Center (2017-present)
  • Study Chair/Principal Investigator, Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES). NHLBI study. (2013-present)
  • Attending Physician, Children's Hospital of Michigan/Detroit Medical Center (2014-present)
  • Voluntary Professor, Pediatrics, University of Miami Miller School of Medicine (2013-present)
  • Graduate Faculty, Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine (2010-present)
  • Graduate Faculty, Epidemiology and Public Health, University of Miami Miller School of Medicine (2009-present)
  • Professor, Medicine (Cardiology), University of Miami Miller School of Medicine (2003-present)
  • Professor, Public Health Sciences, University of Miami Miller School of Medicine (2003-present)
  • Plenary Keynote Speaker, Cuban 8th Cardio-Oncology Symposium (2024–2025)
  • Featured speaker and moderator, Children’s Cardiomyopathy Foundation Webinar (2024)
  • Founder, organizer, co-chair steering committee, co-chair planning committee, 6th International Conference on Cardiomyopathy in Children (2024)
  • Invited Cardiopulmonary Working Group Session Leader, NIH Pediatric HIV-AIDS Cohort (PHACS) study annual investigator meeting (2024)
  • Invited Moderator and Speaker, Children’s Cardiomyopathy Foundation - Experts on Pediatric Cardiomyopathy Educational Webinar Series (2024)
  • Invited Pediatric Grand Rounds Speaker, Pediatrics, Children's Hospital of Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA (2024)
  • Invited Plenary Speaker, NCI-Dana-Farber Childhood Cancer Investigator Meeting (2024)
  • Invited Plenary Speaker, Sixth International Conference on Cardiomyopathy in Children (2024)
  • Invited Plenary Speaker and Session Co-Chair, Second International Conference on Cardio-Oncology in Children (2024)
  • Invited Webinar Speaker, Children’s Cardiomyopathy Foundation - Experts on Pediatric Cardiomyopathy Educational Webinar Series (2024)
  • Judge, University at Buffalo Jacobs School of Medicine and Biomedical Sciences Medical Student Annual Research Forum (2024)
  • Keynote Plenary Speaker, Cardiogenetics Scientific Summit (2024)
  • Moderator, Children’s Cardiomyopathy Foundation Webinar: Evaluating Children with Hypertrophic Cardiomyopathy: Importance of Cardiac MRI (2024)
  • Moderator, Heart University/ICOS/Sofia’s Hope Webinar Series on Pediatric Cardio-Oncology (2024)
  • Organizer, Children’s Cardiomyopathy Foundation Medical Advisory Board Meeting (2024)
  • Organizer, Pediatric Cardiomyopathy Registry Scientific Retreat (2024)
  • Pediatric Grand Rounds Speaker and Visiting Professor, Mayo Clinic, Rochester, MN (2024)
  • Principal Investigator, Organizer, and Chair, Steering Committee, Pediatric Cardiomyopathy Registry, Sofia’s Hope, Inc., and Cincinnati Children’s Hospital Medical Center (2024)
  • Scientific Review Committee Member, HESI THRIVE grant program (2024)
  • Founding and Continuing Member of the Scientific Advisory Committee, Health and Environmental Sciences Institute (HESI) Thrive Program (2023–2024)
  • A. Conger Goodyear Professor and Chair, Pediatrics, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2018–2023)
  • Medical Director, Pediatric Services Business Development, John R. Oishei Children‘s Hospital (2018–2023)
  • Pediatric Chief-of-Service, Kaleida Health (2018–2023)
  • President, UBMD Pediatrics (2018–2023)
  • Attending Physician, Children's Hospital of Michigan/Detroit Medical Center (2014–2020)
  • Professor, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine (2016–2018)
  • Interim Director, Children‘s Research Center of Michigan (2014–2018)
  • Member, Environmental Modulators of Metabolism and Metabolic Disease Interest Group, Center for Urban Responses to Environmental Stressors (NIEHS-CURES), Wayne State University School of Medicine (2014–2018)
  • Carman and Ann Adams Endowed Chair, Pediatric Research, Wayne State University School of Medicine (2013–2018)
  • Member, Wayne State University School of Medicine (2013–2018)
  • Professor, Family Medicine and Public Health Sciences, Wayne State University School of Medicine (2013–2018)
  • Professor, Medicine (Cardiology), Wayne State University School of Medicine (2013–2018)
  • Professor, Molecular Biology and Genetics, Wayne State University School of Medicine (2013–2018)
  • Professor, Obstetrics and Gynecology, Wayne State University School of Medicine (2013–2018)
  • Professor, Oncology, Wayne State University School of Medicine (2013–2018)
  • Professor, Pediatrics, Wayne State University School of Medicine (2013–2018)
  • Professor, Pharmacology, Wayne State University School of Medicine (2013–2018)
  • Schotanus Family Endowed Chair, Pediatrics, Wayne State University School of Medicine (2013–2018)
  • Scientific Member, Barbara Ann Karmanos Cancer Institute (2013–2018)
  • Pediatrician-in-Chief, Children's Hospital of Michigan (2013–2017)
  • President, University Pediatricians (2013–2017)
  • Specialist-in-Chief, Detroit Medical Center (2013–2017)
  • Chair, Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine (2013–2016)
  • Provider, South Florida Community Care Network (2009–2015)
  • Attending Physician, Jackson North Medical Center (2007–2015)
  • Physician, Jackson Memorial Hospital (2004–2015)
  • Director, University of Miami (2009–2014)
  • George E. Batchelor Chair in Pediatrics, University of Miami Miller School of Medicine (2006–2013)
  • Teaching Attending Physician, Holtz Children‘s Hospital of the University of Miami-Jackson Memorial Medical Center (2005–2013)
  • Director, University of Miami (2003–2013)
  • Physician, University of Miami Medical Group (2003–2013)
  • Professor, Pediatrics, University of Miami Miller School of Medicine (2003–2013)
  • Associate Executive Dean of Child Health, University of Miami Miller School of Medicine (2008–2012)
  • Director, University of Miami Miller School of Medicine (2006–2012)
  • Associate Director, Mailman Center for Child Development (2003–2012)
  • Chair, Pediatrics, University of Miami Miller School of Medicine (2003–2012)
  • Chief-of-Staff, Holtz Children‘s Hospital of the University of Miami-Jackson Memorial Medical Center (2003–2012)
  • Director, University of Miami (2003–2012)
  • Co-Director, National Heart, Lung and Blood Institute/University of Rochester (2000–2007)
  • Associate Research Professor, Pediatrics, Boston University School of Medicine (1995–2006)
  • Adjunct Professor, Pediatrics, University of Rochester School of Medicine and Dentistry (2003–2004)
  • Co-Director, University of Rochester Medical Center/Golisano Children’s Hospital at Strong (2002–2003)
  • Courtesy Privileges, Highland Hospital (2001–2003)
  • Director, University of Rochester (1999–2003)
  • Director, Children's Heart Center at Strong (1998–2003)
  • Director, Golisano Children‘s Hospital at Strong (1998–2003)
  • Professor, Oncology, University of Rochester School of Medicine and Dentistry (1998–2003)
  • Attending Pediatrician, University of Rochester Medical Center (1996–2003)
  • Division Chief, University of Rochester Medical Center/Golisano Children‘s Hospital at Strong (1996–2003)
  • Professor, Pediatrics, University of Rochester School of Medicine and Dentistry (1996–2003)
  • Consultant Privileges, Highland Hospital (1998–2001)
  • Assistant Professor, Pediatrics, Harvard Medical School (1992–2000)
  • Associate, Boston Children's Hospital (1991–1999)
  • Director, Center for the Study of Pulmonary and Cardiac Manifestations of Pediatric HIV Infection (1989–1999)
  • Director, Boston Children's Hospital (1988–1996)
  • Director, Boston City Hospital (1988–1996)
  • Visiting Assistant Physician, Boston City Hospital (1988–1996)
  • Assistant Clinical Professor, Pediatrics, Boston University School of Medicine (1990–1995)
  • Assistant, Boston Children's Hospital (1987–1991)
  • Instructor, Pediatrics, Harvard Medical School (1986–1991)
See all (105 more)

Awards and Honors:
  • Inaugural Sofia’s Hope “Champion of Hope” Awardee (2024)
  • Consultant (2024)
  • Investigator (2024)
  • Founder, Co-Leader, and Speaker (2024)
  • Plenary Keynote Speaker (2024)
  • Invited Plenary Speaker and Session Co-Chair (2024)
  • Moderator (2024)
  • Organizer (2024)
  • Keynote Plenary Speaker (2024)
  • Ranked #920 in the US among Top Scientists (2024)
  • Co-investigator (2024)
  • Principal Investigator, Organizer, and Chair, Steering Committee (2024)
  • Organizer (2024)
  • Invited Pediatric Grand Rounds Speaker (2024)
  • Thomas L. Force Pioneer Lifetime Achievement Award (2024)
  • Notified publications have been cited 136,925 times (2024)
  • Pediatric Grand Rounds Speaker and Visiting Professor (2024)
  • Moderator (2024)
  • Editor-in-Chief (2024)
  • Cited (2024)
  • Featured speaker and moderator (2024)
  • Consultant (2024)
  • Google Scholar (2024)
  • Highly ranked scholar-lifetime (2024)
  • Ranked #1527 in United States among Best Scientists for 2024 and 2670 globally (2024)
  • Stakeholder Reviewer (2024)
  • Principal Investigator (2024)
  • Invited Cardiopulmonary Working Group Session Leader (2024)
  • Invited to continue to be Member of the External Advisory Board (2024)
  • Consultant (2024)
  • Invited Cardiopulmonary Working Group Session Leader (2024)
  • Stakeholder Reviewer (2024)
  • Current Cumulative Grant Budget (2024)
  • Invited to continue to be Member of the External Advisory Board (2024)
  • Principal Investigator (2024)
  • Editor-in-Chief (2024)
  • "Cardiomyopathy-associated pathogenic variants in pediatric myocarditis: a study from the Pediatric Cardiomyopathy Registry" - Awarded one of three submitted abstracts for best pediatric cardiology research in 2023. Circulation 2024. (2024)
  • Invited Plenary Speaker (2024)
  • Scientific Review Committee Member (2024)
  • Founder, Organizer, Co-chair Steering Committee, Co-chair Planning Committee (2024)
  • Principal Investigator, Organizer, Chair, Planning Committee, and Chair, Steering Committee (2024)
  • Top Five Cited Authors with The Highest Frequency (2024)
  • Invited Plenary Speaker (2024)
  • Invited Grand Rounds Speaker (2024)
  • Invited to be the 2024 Robert T. Wong, M.D. Keynote Lecturer (2024)
  • Invited Grand Rounds Speaker (2024)
  • Highly Recognized (2024)
  • Chief Medical Officer (2024)
  • Invited Moderator and Speaker (2024)
  • Invited Webinar Speaker (2024)
  • Consultant (2024)
  • Top cited article in 2022 titled "Disruption of healthcare: Will the COVID pandemic worsen non-COVID outcomes and disease outbreaks?" (2024)
  • Developer, Leader and Mentor of Senior Scholar Program in Pediatric Cardiomyopathy (2024)
  • Becker’s Hospital Review (2023)
  • Invited Member External Advisory Committee (2023)
  • Invited Plenary Speaker (2023)
  • Invited Featured Keynote Speaker (2023)
  • Principal Investigator (2023)
  • Invited and Accepted Investigator (2023)
  • Invited Plenary Speaker and Faculty Member (2023)
  • Invited Faculty (2023)
  • Ranked #920 in the US among Top Scientists for 2022 (2023)
  • Invited Keynote Speaker (2023)
  • Founding and Continuing Member of the Scientific Advisory Committee (2023)
  • Invited Member (2023)
  • Invited Investigator (2023)
  • Invited Site Principal Investigator for Buffalo, Rochester, and Syracuse, NY (2023)
  • Video Feature (2023)
  • Member, Clinical Advisory Board (2023)
  • External Advisory Board Member (2023)
  • 2023 Invited Plenary Speaker (2023)
  • Invited Faculty Member (2023)
  • Chair, External Advisory Committee (2023)
  • Invited Lead Writer (2023)
  • Invited Member (2023)
  • Invited Speaker (2023)
  • Featured Speaker (2023)
  • Invited Plenary Speaker (2022)
  • Meeting Participant and Invited Speaker (2022)
  • Invited to participate as a speaker and meeting leader (2022)
  • Session Leader (2021)
  • Buffalo Translational Consortium Clinical Research Achievement Award Recipient and Invited Speaker (2021)
  • Expertscape: World Expert on Cancer Survivors (2019)
  • NICHD: Sumner J. Yaffe Memorial Lecturer (2018)
  • Amgen, Inc.: Consultant, Pediatric Dilated Cardiomyopathy Drugs (2018)
  • University of Hawaii Center of Biomedical Research Excellence in Diabetes: Chair, COBRE-Diabetes External Advisory Board (2017)
  • Web of Science: Top 500 Researchers 2010-2014 (2017)
  • University of Tennessee School of Medicine: Mac Armour Memorial Lectureship in Pediatric Cardiology (2016)
  • Essential Science Indicators (Thompson Reuters): Top 1% of Global Scientists (2016)
  • Wayne State University Academic Scholars: Elected Member (2016)
  • Marquis Who's Who Publication Board: 10-Year Anniversary Listee (2015)
  • Children’s Cardiomyopathy Foundation/Kyle John Rymiszewski Foundation: Director, Scholar in Pediatric Cardiology Program (2015)
  • St. Jude Lifetime Cohort: External Advisory Board Member (2014)
  • University of Miami School of Law: Achievement Award for Environmental Justice (2014)
  • Bill & Melinda Gates Foundation: Chair, Writing Group 6 on Cardiomyopathy (2013)
  • Marquis Who‘s Who Publication Board: 5-Year Anniversary Listee (2012)
  • Children’s Cardiomyopathy Foundation: Invited Participant and Leader, Annual Medical Advisors Meeting and Grant Reviews (2012)
  • International Association of Pediatricians/International Association of Healthcare Professionals: Top Pediatrician (2012)
  • ProCardio European Commission Study: Scientific Advisory Board Member (2011)
  • NHLBI: Grant Reviewer, Special Emphasis Review Panel (2011)
  • Axio Research, LLC: CTI PIX 306 Internal Data Monitoring Committee Member (2011)
  • University of Chicago/Comer Children’s Hospital: Albert Dorfman, MD, PhD, Distinguished Lecturer and Visiting Professor (2011)
  • Weill Cornell University Medical College and New York-Presbyterian Phyllis & David Komansky Center for Children’s Health: 2nd Annual Mary Allen Engle Visiting Lecturer and Visiting Professor (2011)
  • Leukemia and Lymphoma Society: Triathlon Inspiration Dinner Mission Speaker (Miami, FL) (2010)
  • Leukemia and Lymphoma Society: Southern Florida Chapter Leadership Council Member (2010)
  • Roche Corporation Division of Cardiovascular Safety Pharmacology: Invited Scientist and Seminar Speaker (2010)
  • NICHD: Publications Committee Member (2010)
  • NICHD PHACS Study: Chair, Cardiology Task Force (2010)
  • Children’s Cardiomyopathy Foundation: Chair, Scientific Review Committee (2010)
  • Cell Therapeutics, Inc.: Consultant, Pediatric EMA Pixantrone Investigative Plan (2010)
  • University of Toronto: Robert Freedom Lecturer and Visiting Professor (2009)
  • Women’s Cancer Association of the University of Miami: John D. Nolan Award (2009)
  • American Heart Association: Miami-Dade Heart and Stroke Ball Second Cor Vitae (Heart of Life) Award Nominee (2009)
  • Women’s Cancer Association of the University of Miami: Archie & Bill Clot Memorial Award (2008)
  • National Cancer Institute: Exemplar of NCI-Funded Translational Research (Pediatric Oncology Translational Research Program) (2008)
  • U.S. Congressional Commendation (2006)
  • Smila, Cherkasy Oblast, Ukraine: Medal of Smila (2006)
  • Royal Society of Medicine Symposium: Keynote Address Speaker (2006)
  • University of Miami Miller School of Medicine: Genevieve Abraham Award (2006)
  • New York University School of Medicine: First Ross Visiting Professorship in Pediatrics Recipient (2006)
  • South Florida Business Journal: Health Care Heavy Hitters Award (2005)
  • American Heart Association: Scientific Sessions 2005 Poster Competition in Clinical Science Award (2005)
  • NIH: PHACS Cardiology Group Member (2005)
  • Columbia University: Top NIH Grantee Recognition (2005)
  • Women‘s Cancer Association of the University of Miami: Madelon Ravlin Award for Cancer Research (2005)
  • El Nuevo Herald Newspaper: Figure of the Day (2004)
  • University of Florida Division of Pediatric Cardiology/Southern Pediatric Cardiology Association of Orlando: Francisco A. Hernandez Annual Lectureship (2004)
  • University of Miami Miller School of Medicine: R. Rodney Howell, MD Invited Lectureship (2004)
  • Rochester Business Journal: Health Care Achievement Awards - Physician Finalist (2003)
  • Boston City Hospital/Boston University School of Medicine: Annual Resident Teaching Award (1992)
  • Tenafly High School: Distinguished Alumnus Award (1992)
  • W. B. Saunders Resident Research Award (1984)
  • Rainbow Pediatric Pharmacology Research Award (1983)
  • Gordon Research Conference on Developmental Biology Scholarship (1977)
  • University of Pennsylvania: Sigma Xi Scientific Research Honor Society (1977)
  • First Federal Academic Achievement Scholarship (1977)
  • Castle Connolly: America‘s Top Doctors (2009-2010)
  • NICHD National Children‘s Study Full Steering Committee: Committee Member (2008-2013)
  • NICHD National Children‘s Study Executive Steering Committee: Invited Voting Member (2008-2011)
  • Consumers’ Research Council of America: America‘s Top Pediatricians (2010-2012)
  • Marquis Who’s Who in the World (2011-present)
  • Camp Boggy Creek Medical Advisory Committee: Invited Charter Member (2008-2013)
  • Best Doctors in America (2001-2013, 2015-2018)
  • Florida Monthly Magazine: Florida‘s Best Doctors (2005-2006)
  • American College of Cardiology-Bristol Laboratories Affiliate: Cardiology Fellow Research Travel Award (1987-1988)
  • NIH/NHLBI: Clinical Investigator Award (1986-1991)
  • Full Member, Sigma Xi
  • Marquis Who’s Who in America (2006, 2011-present)
  • Jackson Memorial Hospital: Super Doctors (2012, 2015-present)
  • Premium Professional Plus Gold Heart Member
  • Fellow of the American Heart Association (FAHA)
  • American Medical Association: Physician Recognition Award (1987-2002)
  • Consumers’ Research Council of America: America‘s Top Cardiologists (2006-2013)
  • American Medical Association Section on Medical Schools: University of Miami Representing Member (2008-2014)
  • American Academy of Pediatrics District X and Child Health Planning & Advocacy Committee of Florida Children’s Medical Services: Invited Member (2008-2012)
  • Roche Corporation: Consultant, Cardiovascular Safety Pharmacology (2010-2012)
  • Healthgrades: Honor Roll Award (2015-present)
  • NICHD National Children‘s Study Southeast U.S. Principal Investigator’s Group: Co-Chair (2008-2011)
  • NHLBI: Steering Committee Member, Training Grant in Cardiovascular Signaling Years 34-40 (2010-2013)
  • Active Member

Grants and Sponsored Research:
  • January 2021–December 2026
    The Alfiero Foundation Grant
    The Alfiero Child Health Research Institute
    Role: Principal Investigator
  • June 2019–June 2026
    Sofia's Hope Coordinator/Second International Pediatric Cardio-Oncology Conference
    Sofia's Hope
    Role: Principal Investigator
  • May 2021–April 2026
    Optimizing Chest Compressions for Bradycardia during Neonatal Resuscitation
    NICHD
    Role: Co-Investigator
  • March 2021–February 2026
    Immunomodulation of Galectin-3 to Prevent Radiation-Induced Myocardial Fibrogenesis
    NHLBI
    Role: Principal Investigator
  • July 2019–January 2026
    Children’s Cardiomyopathy Foundation Research Scholar 2 & 3 in Pediatric Cardiomyopathy: PCMR
    Children’s Cardiomyopathy Foundation
    Role: Principal Investigator
  • January 2019–January 2026
    Pediatric Cardiomyopathy Registry (PCMR)
    Children‘s Cardiomyopathy Foundation
    Role: Principal Investigator
  • October 2023–October 2025
    Sixth International Conference on Cardiomyopathy in Children Coordinator Support
    Children’s Cardiomyopathy Foundation
    Role: Principal Investigator
    $15,500
  • April 2022–March 2025
    Epigenetic dysregulation of inflammation linked to longitudinal cardiotoxicity in perinatal HIV infection
    NIAID
    Role: Co-Principal Investigator
    $219,038
  • March 2022–March 2025
    C19: A phase 2/3, interventional safety, pharmacokinetics, and efficacy, open-label, multicenter, single-arm study to investigate orally administered pf-07321332 (nirmatrelvir)/ritonavir in non-hospitalized symptomatic pediatric patients
    Parexel/Pfizer
    Role: Principal Investigator
  • March 2024–February 2025
    Pediatric Cardiomyopathy Registry Learning Collaborative Research Retreat
    Secretome Therapeutics, Inc.
    Role: Principal Investigator
  • September 2019–August 2024
    A Prospective Cohort Study Assessing the Clinical Status and the Health-related Quality of Life in Youth with Hypertrophic Cardiomyopathy
    NHLBI
    Role: Co-Principal Investigator
  • November 2018–August 2024
    Kyle John Rymiszewski Foundation Research Scholar in Pediatric Cardiomyopathy: PCMR
    Kyle John Rymiszewski Foundation
    Role: Principal Investigator
  • October 2022–June 2024
    An AI-based multifunctional hand-held Lumify ultrasound for automatic and intelligent quantitative assessment of lung injuries, diseases, and traumatic injuries in a mass-casualty incident
    HHS-BARDA/Philips Research
    Role: Principal Investigator
  • July 2019–June 2024
    Integrated Basic and Translational Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity
    Role: Co-Investigator
  • February 2018–January 2024
    Prognostic Significance of MicroRNA Expression in Children with Cardiomyopathy
    National Heart, Lung, and Blood Institute
    Role: Principal Investigator
  • September 2017–May 2023
    Cardiac Toxicity in Perinatally HIV-infected Adolescents and Young Adults: PHACS
    NHLBI
    Role: Principal Investigator
  • April 2018–March 2023
    Adverse Health Outcomes in Testicular Cancer Survivors: Discovery and Translation. (RO1 Parent Announcement PA-16-160)
    NCI
    Role: Principal Investigator
  • July 2019–June 2021
    First International Pediatric Cardio-Oncology Conference
    Sofia's Hope
    Role: Principal Investigator
  • November 2018–May 2021
    Cardiac Toxicity in Perinatally HIV-Infected Adolescents and Young Adults, a Longitudinal Study
    National Heart, Lung, and Blood Institute
    Role: Principal Investigator
  • April 2019–March 2021
    Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
    National Cancer Institute
    Role: Co-Principal Investigator
  • October 2018–July 2020
    Pediatric HIV/AIDS Cohort Study (PHACS) Coordinating Center
    Tulane University
    Role: Principal Investigator
  • July 2019–June 2020
    Research Scholar in Pediatric Cardiomyopathy
    Children‘s Cardiomyopathy Foundation
    Role: Principal Investigator
  • June 2024
    Pediatric Cardiomyopathy Registry Retreat and Children’s Cardiomyopathy Foundation Medical Advisors Meeting Support
    Children’s Cardiomyopathy Foundation
    Role: Principal Investigator
    $25,000
  • May 2024
    Children’s Cardiomyopathy Foundation Executive Director Support
    Children’s Cardiomyopathy Foundation
    Role: Principal Investigator
    $180,000
  • April 2024
    Children’s Cardiomyopathy Foundation Patient and Family Advocacy Coordinator Support
    Children’s Cardiomyopathy Foundation
    Role: Principal Investigator
    $50,000
  • June 2023
    Dr. Steven E. Lipshultz Fund Endowment Agreement (Board-Designated Fund), University at Buffalo Foundation, Inc
    Donor
    Role: Principal Investigator
    $1,016,731
  • February 2022
    Pfizer Clinical Trial for the Treatment of COVID-19 in pediatric participants who are at risk of progression to severe disorder – a Phase 2/3 study
    Pfizer
    Role: Principal Investigator
  • Elucidating the Genetic Susceptibility to Anthracycline Cardiotoxicity
    NIH
    Role: Co-Investigator
See all (18 more)

Journal Articles:

See all (439 more)

Books and Book Chapters:

  • Lipshultz SE, Messiah SE, Sarno LA, Xie L, Brummer H, Brophy PD, Balakrishnan P. (2025) Signs and Symptoms in Pediatrics, Second Edition. In: High Blood Pressure. American Academy of Pediatrics
  • Lipshultz SE, Maywalt D. (2024) Cardiovascular Toxicology, Comprehensive Toxicology, Fourth Edition, Volume 13-15. In: Anthracycline, Trastuzumab, and Cardiovascular Toxicity. Elsevier Ltd
  • Bansal N, Lim H, Lipshultz SE. (2024) In: Chapter 25: Innovation in Pediatric Cardio-Oncology. Elsevier
  • Lipshultz SE, Adams MJ, Barach P. (2023) Pediatric Cardiology: Fetal, Pediatric, and Adult Congenital Heart Diseases. In: Research in Pediatric Cardiology. Springer Nature
  • Lipshultz SE. (2020) In: "Systemic Diseases". Wolters Kluwer, 446-470.
  • Hutchins KK, Steiner R, Lipshultz ER, Sallan SE, Lipshultz SE. (2020) In: "Cardiotoxicity After Childhood Cancer Treatment". Springer, 3-15.
  • Wilkinson JD, Kumar A, Westphal JA, Czachor JD, Razoky H, Lipshultz SE. (2019) In: "The Epidemiology and Global Burden of Cardiomyopathy". Oxford University Press
  • Amdani S, Bansal N, Lipshultz ER, Adams MJ, Lipshultz SE. (2019) In: "Survivorship: Pediatric Cancer Survivors". CRC Press
  • Cochran TR, Franco VI, Scully R, Lipshultz SE. (2018) In: "Anthracycline, Trastuzumab, and Cardiovascular Toxicity". Elsevier, 432-446.
  • Bansal N, Gerschensohn M, Miller TL, Sallan SE, Czachor J, Razoky H, Hill A, Mestre M, Lipshultz SE. (2018) In: "Drug-Induced Mitochondrial Cardiomyopathy and Cardiovascular Risks in Children". John Wiley & Sons, Inc., 529-546.
  • Bansal N, Akam-Venkata J, Franco VI, Lipshultz SE. (2018) In: "Heart Failure in Pediatric Oncologic Disease". Elsevier, 425-443.
  • Schultheiss HP, Caforio A, Fairweather DL, Hershberger R, Lipshultz SE, Liu P, Matsumori A, McMurray J, Priori S. (2017) In: "Epidemiology of Dilated Cardiomyopathy". Nature Reviews Disease Primers
  • Lipshultz SE, Patel N, Franco VI, Fisher SD. (2017) In: "Late Cardiac Effects in Childhood Cancer Survivors". Elsevier
  • Bansal N, Nofal R, Aggarwal S, Franco VI, Lipshultz ER, Sallan SE, Lipshultz SE. (2017) In: "Cardiac Considerations in the Treatment of Cancer in Infants and Children". People‘s Medical Publishing House
  • Hutchins KK, Steiner R, Lipshultz ER, Sallan SE, Lipshultz SE. (2017) In: "Cardiotoxicity after Childhood Cancer Treatment". Springer
  • Amdani SM, Bansal N, Franco VI, Adams MJ, Lipshultz SE. (2017) In: "Cardiovascular Effects of Anthracycline Chemotherapy and Radiation Therapy in Children with Cancer". Elsevier
  • Briston DA, Cochran TR, Sambatakos PJ, Brown SR, Lipshultz SE. (2015) In: "Cardiovascular Effects of Cancer Therapy". Springer International Publishing, 167-199.
  • Fisher SD, Lipshultz SE. (2015) In: "Cardiovascular Abnormalities in HIV-Infected Individuals". Elsevier, 1624-1635.
  • Lipshultz SE, Miller TL, Wilkinson JD, Scott GB, Somarriba G, Cochran TR, Mas CM, Fisher SD. (2015) In: "Association of Human Immunodeficiency Virus Infection with Exposure to Highly Active Antiretroviral Treatment and Its Adverse Cardiovascular Effects". Elsevier
  • Chandar J, Zilleruelo G, Messiah SE, Lipshultz SE. (2015) In: "High Blood Pressure". American Academy of Pediatrics
  • Barach PR, Jacobs JP, Laussen PC, Lipshultz SE. (2015) In: "Introduction". Springer
  • Barach PR, Jacobs JP, Laussen PC, Lipshultz SE. (2015) In: "Introduction". Springer
  • Barach PR, Jacobs JP, Laussen PC, Lipshultz SE. (2015) In: "Epilogue - A Vision for the Future". Springer
  • Harmon W, Rusconi P, Miller TL, Lipshultz SE. (2015) In: "Heart Failure". American Academy of Pediatrics
  • Doshi N, Franco VI, Chang AC, Lipshultz SE. (2015) In: "Cardiovascular System". Springer Science+Business Media, 93-110.
  • Qureshi MY, Lipshultz SE. (2015) In: "Systemic Diseases". Wolters Kluwer, 446-470.
  • Alvarez JA, Miller Tl, Messiah SE, Lipshultz SE. (2015) In: "Lipid Abnormalities". American Academy of Pediatrics
  • Wilkinson JD, Westphal JA, Ross SW, Dauphin DD, Lipshultz SE. (2015) In: "The Value of National Institutes of Health (NIH) Registry-Based Research in Identifying Childhood Cardiac Disease Outcomes: The Pediatric Cardiomyopathy Registry Experience". Springer
  • Lipshultz SE, Miller TL, Wilkinson JD, Mestre MA. (2013) In: "National Children’s Study". Springer
  • Landy DC, Miller TL, Wilkinson JD, Lipshultz SE. (2013) In: "Cardiac Considerations in the Treatment of Cancer in Infants and Children". People's Medical Publishing House
  • Lipshultz SE, Sanchez J, Carrillo A, Preble S, Scully RE. (2012) In: "Cardiac Effects of Growth Hormone Treatment in Pediatric Populations". Nova Science Publishers, Inc., 125-138.
  • Fisher SD, Lipshultz SE. (2012) In: "Cardiovascular Abnormalities in HIV-Infected Individuals". Elsevier, 1618-1627.
  • Ewer MS, Lipshultz SE. (2012) In: "Cardiovascular Consequences in Adult Survivors of Childhood Cancer". Elsevier
  • Lipshultz SE, Miller TL, Messiah SE. (2012) In: "Preface". Springer-Verlag London, 217-228.
  • Brown SR, Lipshultz SE. (2012) In: "Childhood Metabolic Syndrome and Cancer Risk". Springer-Verlag London, 217-228.
  • Qureshi MY, Messiah SE, Miller TL, Lipshultz SE. (2012) In: "Effects of Metabolic Syndrome on Atherosclerosis in Childhood". Springer-Verlag London, 93-116.
  • Qureshi MY, Wilkinson JD, Lipshultz SE. (2012) In: "The Relationship of Childhood Obesity with Cardiomyopathy and Heart Failure". Springer-Verlag London, 199-215.
  • Messiah SE, Arheart KL, Lipshultz SE, Miller TL. (2011) In: "Prevalence of the Metabolic Syndrome in U.S. Youth". Elsevier, 107-115.
  • Scully R, Lipshultz SE. (2010) In: "Cardiovascular Toxicity of Antitumor Drugs: Dimensions of the Problem in Children". John Wiley & Sons, Inc., 97-126.
  • Lipshultz SE, Sanchez J, Carrillo A, Preble S, Scully RE. (2010) In: "Cardiac Effects of Growth Hormone Treatment in Pediatric Populations". Nova Science Publishers, Inc.
  • Scully R, Miller A, Grant Y, Lipshultz SE. (2010) In: "Anthracycline, Herceptin, and CV Toxicity". Elsevier, 413-427.
  • Adams MJ, Constine LS, Lipshultz SE. (2010) In: "Radiation-Induced Heart Disease". Mosby/Elsevier, 1833-1841.
  • Sharma TS, Perez Loughlin L, Miller TL, Lipshultz SE. (2009) In: "Heart Failure". American Academy of Pediatrics, 2717-2726.
  • Alvarez JA, Miller TL, Starc TJ, McGrath KA, Lipshultz SE. (2009) In: "Preventive Cardiology". American Academy of Pediatrics, 278-293.
  • Sokol KC, Messiah SE, Buzzard CJ, Lipshultz SE. (2009) In: "High Blood Pressure in Infants, Children, and Adolescents". American Academy of Pediatrics, 1579-1590.
  • Scully RE, Miller TL, Lipshultz SE. (2008) In: "Detecting Anthracycline-Induced Cardiotoxicity in Survivors of Childhood Cancer". , 454-458.
  • Barry EV, Lipshultz SE, Sallan SE. (2008) In: "Anthracycline-Induced Cardiotoxicity: Natural History, Risk Factors, and Prevention". , 448-453.
  • Lipshultz SE, Rusconi P, Scully RE. (2008) In: "Assessment of Cardiotoxicity During Anti-Cancer Therapy". Prous Science S.A. and Thompson Reuters, 183-198.
  • Mustian KM, Adams MJ, Schwartz RG, Lipshultz SE, Constine LS. (2008) In: "Cardiotoxic Effects of Radiation Therapy in Hodgkin‘s Lymphoma and Breast Cancer Survivors and the Potential Mitigating Effects of Exercise". Springer-Verlag Berlin Heidelberg, 103-115.
  • Fisher SD, Lipshultz SE. (2008) In: "Cardiovascular Abnormalities in HIV-Infected Individuals". Elsevier, 1793-1814.
  • Adams MJ, Prosnitz RG, Constine LS, Marks LB, Lipshultz SE. (2008) In: "Screening for Cardiovascular Disease in Survivors of Thoracic Radiation". Springer-Verlag Berlin Heidelberg, 47-59.
  • Natarajan S, McHenry MB, Lipsitz S, Klar N, Lipshultz SE. (2007) In: "Agreement Between Two Ratings with Different Ordinal Scales". Springer Science+Business Media, 139-148.
  • Sharma TS, Lipshultz SE. (2007) In: "Cardiac Complications". American Academy of HIV Medicine, 591-591.
  • Lipshultz SE. (2007) In: "Drug Cardiotoxicity Research in Children". Nova Science Publishers, Inc.
  • Constine LS, Lipshultz SE. (2007) In: "How Cytotoxic Therapy for Hodgkin’s Lymphoma Can Break Your Heart". , 1-7.
  • Newburger JW, Harmon WG, Lipshultz SE. (2006) In: "Kawasaki Disease". Saunders Elsevier, 497-503.
  • Dadlani GH, Harmon WG, Lipshultz SE. (2006) In: "Dilated Cardiomyopathy". Saunders Elsevier, 248-263.
  • Dadlani GH, Lipshultz SE. (2006) In: "Cardiac Problems". Cambridge University Press, 554-566.
  • Tisma-Dupanovic S, Harmon WG, Adams MJ, Dadlani GH, Kozlowski A, Duffy S, Harbowy L, Zareba K, French C, McLaughlin K, Lipshultz SE. (2005) In: "Cancer Therapy-Related Cardiotoxicities". Taylor & Francis, 665-738.
  • Fisher SD, Lipshultz SE. (2005) In: "Cardiovascular Abnormalities in HIV-Infected Individuals". Elsevier, 1719-1730.
  • Dadlani GH, Lipshultz SE. (2005) In: "Cardiac Problems". Cambridge University Press, 468-478.
  • Adams MJ, Duffy SA, Constine LS, Lipshultz SE. (2005) In: "Cardiovascular Effects of Cancer Therapy". Springer-Verlag Berlin Heidelberg, 133-159.
  • Fisher SD, Lipshultz SE. (2005) In: "Cardiovascular Manifestations of HIV Infection in Children". Lippincott Williams & Wilkins
  • Hale ER, Lipshultz SE, Constine LS. (2005) In: "Latent Cardiac Injury Following the Double-Edged Sword of Chemotherapy and Radiation". , 739-746.
  • Constine LS, Lipshultz SE. (2004) In: "Heart of the Matter: Risk Factors for Premature Cardiovascular Disease in Cancer Survivors". , 418-424.
  • Hinkle AS, Proukou CB, Deshpande SS, Duffy SA, Kozlowski AM, French CA, Lipshultz SE. (2004) In: "Cardiotoxicity Caused by Chemotherapy". Edward Arnold, 85-100.
  • Adams MJ, Constine LS, Lipshultz SE. (2004) In: "Radiation". Mosby, 1583-1590.
  • Herman E, Lipshultz SE, Ferrans VJ. (2003) In: "The Use of Cardiac Biomarkers to Detect Myocardial Damage Induced by Chemotherapeutic Agents". Humana Press, 87-110.
  • Keesler MJ, Fisher SD, Lipshultz SE. (2003) In: "Abnormal Cardiovascular Function in HIV-Infected Infants and Children". W.B. Saunders, 303-320.
  • Fisher SD, Lipshultz SE. (2003) In: "Cardiac Disease". Elsevier Science, 814-826.
  • Fisher SD, Lipshultz SE. (2001) In: "AIDS and the Cardiovascular System". McGraw-Hill
  • Fisher SD, Lipshultz SE. (2001) In: "AIDS and the Cardiovascular System". W.B. Saunders, 2211-2222.
  • Lipshultz SE. (2001) In: "Congestive Heart Failure". Mosby, 1975-1979.
  • Starc TJ, McGrath KM, Lipshultz SE. (2001) In: "Preventive Cardiology". Mosby, 311-317.
  • Adams MJ, Constine LS, Lipshultz SE. (2001) In: "Radiation Effects on the Heart". Mosby
  • Harmon WG, Lipshultz SE. (2001) In: "Kawasaki’s Syndrome". W.B. Saunders, 550-553.
  • Buzzard C, Lipshultz SE. (2001) In: "Hypertension". Mosby, 1142-1149.
  • Grenier MA, Lipshultz SE. (1999) In: "Cardiac Disease". Churchill Livingstone, 680-698.
  • Grenier MA, Lipshultz SE. (1999) In: "Cardiac Problems". Lippincott Williams & Wilkins, 376-384.
  • Giantris A, Lipshultz SE. (1998) In: "Cardiac Therapeutics in HIV-Infected Patients". Chapman & Hall, 387-422.
  • Lipshultz SE, Bancroft EA, Boller AM. (1998) In: "Cardiovascular Manifestations of HIV Infection in Children". Williams & Wilkins, 335-361.
  • Wong J, Lipshultz SE. (1998) In: "Cardiovascular Complications of Pharmacotherapeutic Agents (Excluding the Antiretrovirals) in Pediatric HIV Infection". Chapman & Hall, 331-344.
  • Lipshultz SE, Bancroft E, Boller AM. (1998) In: "Human Immunodeficiency Virus in Childhood". Lea and Febiger, 1823-1850.
  • Lipshultz SE, Colan SD, Grenier MA. (1998) In: "Left Ventricular Dysfunction in HIV-Infected Infants and Children". Chapman & Hall, 141-153.
  • Grenier MA, Lipshultz SE. (1998) In: "Left Ventricular Hypertrophy in HIV Disease". Chapman & Hall, 111-140.
  • Moorthy LN, Lipshultz SE. (1998) In: "Cardiovascular Monitoring of HIV-Infected Patients". Chapman & Hall, 345-386.
  • Boller AM, Al-Attar I, Orav EJ, Lipshultz SE. (1998) In: "Cardiovascular Morbidity and Mortality in Pediatric HIV". Chapman & Hall, 77-97.
  • Hoffman M, Lipshultz SE, Miller TL. (1998) In: "Malnutrition and Cardiac Abnormalities in the HIV-Infected Patient". Chapman & Hall, 133-139.
  • Lipshultz SE. (1994) In: "Cardiovascular Manifestations of Pediatric HIV Infection". Williams & Wilkins, 483-511.
  • Lipshultz SE, Colan SD. (1993) In: "The Use of Echocardiography and Holter Monitoring in the Assessment of Anthracycline-Treated Patients". Wiley-Liss, 45-62.
  • Bansal N, Amdani S, Akam-Venkata J, Lipshultz ER, Maywalt D, Lipshultz SE. (1900) Chapter 32 - Heart Failure in Pediatric Oncologic Disease. In: Heart Failure in Pediatric Oncologic Disease. Elsevier, 425-443.
See all (81 more)

Abstracts:

  • Astha Burande, BSc, Lisa Hornberger, MD, Oana Caluseriu, MD, Shabnam Peyvandi, MD, MAS, Elijah Bolin, MD, Tiscar Cavalle-Garrido, MD, Sue Chandra, MD, James Cnota, MD, MS, Jennifer Conway, MD, Sara Creighton, MD, Bettina Cuneo, MD, Marlayna Despres, MD, Tam Doan, MD, RDCS, J. Scott Doucet, RDCS, Michelle Grenier, MD, Whitnee Hogan, MD, Michelle Kaplinski, MD, MPH, Mahima K Bijji, BSc (Hons.), Ann Kavanaugh-Mchugh, MD, Sam Keller, MD, Elena Kwon, MD, Steven Lipshultz, MD, Amara Majeed, MBBS, MD, Gitanjali Mansukhani, MD, Amanda McIntosh, MD, Deani McVadon, MD, Erik Michelfelder, MD, Michelle Miller, MD, Caitlin Milligan, MD, PhD, Seema Mital, MD, Adriana Montes Gil, MSN, CPNP-PC, Anita Moon-Grady, MD, Neda Mulla, MD, sheetal patel, MD, Cathleen Pruitt, MD, MSc, Amna Qasim, MD, Hari Rajagopal, MBBS, Sanghee Ro, MD, David Schidlow, MD, MMus, Kristin Schneider, MD, Ranjini Srinivasan, MD, Jennifer Sutton, MMHC, RDCS, RDMS, carolyn taylor, MD, and Angela McBrien, MB BCH, MD. (2024) Multicenter study of primary fetal cardiomyopathy: clinical outcomes and genetic etiologies, a Fetal Heart Society Research Collaborative Study. Circulation, (Nov), (4122486)
  • Vicentino ARR, Karimpour-Fard A, Stauffer BL, Lipshultz SE, Miyamoto SD, Lavine KJ, Sucharov CC, for the Pediatric Cardiomyopathy Registry Investigators. (2024) Distinguishing serum protein patterns between heart failure and recovered patients provide insights into pediatric dilated cardiomyopathy as a single disease. International Society for Heart Research (ISHR), (Jun)
  • Van Dyke R, Sawyer G, Williams PL, Yu W, Attia E, Gerschenson M, Lipshultz S for the Cardiac Toxicity Study of the Pediatric HIV/AIDS Cohort Study. (1900) Longitudinal evaluation of inflammatory biomarkers among youth and young adults with perinatal HIV and perinatal HIV exposure. Conference on Retroviruses and Opportunistic Infections. San Fransisco, CaliforniaUnited States (Jan), (1405.1413.0.2781.2025) Poster
  • Sawyer G, Yao TJ, Williams P, Lipshultz S, Urbina EM, Jacobson DL, Colan S. (1900) Left ventricular mass adjustment for body size in youth with perinatal HIV or perinatal HIV exposure. Conference on Retroviruses and Opportunistic Infections. San Fransisco, CaliforniaUnited States (Jan), (1405.1421.0.2667.2025) Poster

Professional Memberships:
  • American Heart Association: Fellow (FAHA) (2009–present)
  • American Heart Association/American Stroke Association: Premium Professional Plus Gold Heart Member (2008–present)
  • Association of American Physicians (2007–present)
  • Southern Medical Association: Institutional Member (2007–present)
  • National Association of Children’s Hospitals (2005–present)
  • Children’s Hospital Association (2005–present)
  • Greater Miami Pediatric Society (2003–2013)
  • Association of Medical School Pediatric Department Chairs (2003–2012)
  • Florida Association of Children’s Hospitals (2003–present)
  • Florida Medical Association (2003–present)
  • Children's Oncology Group (2000–present)
  • American Pediatric Society (1999–present)
  • Society for Pediatric Research (1996–present)
  • American Heart Association: Council of Cardiovascular Diseases in the Young (1987–present)
  • American Heart Association: Council of Epidemiology and Prevention (1987–present)
  • American Academy of Pediatrics: Fellow (FAAP) (1986–present)
See all (6 more)

Presentations:
  • "Circulating miRNAs are differentially expressed in pediatric dilated cardiomyopathy patients with favorable vs. poor outcomes" Accepted for presentation as an abstract at the American Heart Association meeting in November 2024 (2024)
  • "Clinical Cancer Survivorship Research: Learning Collaboratives, Lessons Learned, and Active Research Findings & Dr. Jacob Adams Lecture" Second International Conference on Cardio-Oncology in Children (2024)
  • "History of the Discovery and Development of Dexrazoxane" 2nd International Cardio-Oncology Conference (2024)
  • "Implementation of Pediatric Cardio-Oncology Clinical Research to Improve Lifespan Quality of Life: Uses, Misuses, Abuses, and Disuses" 2nd International Conference on Cardio-Oncology in Children (2024)
  • "Left ventricular mass adjustment for body size in youth with perinatal HIV or perinatal HIV exposure" Conference on Retroviruses and Opportunistic Infections (2024)
  • "Longitudinal evaluation of inflammatory biomarkers among youth and young adults with perinatal HIV and perinatal HIV exposure" Conference on Retroviruses and Opportunistic Infections (2024)
  • "Making Patient Quality of Life an Active Research Priority" 2nd International Cardio-Oncology Conference (2024)
  • "Multicenter study of primary fetal cardiomyopathy: clinical outcomes and genetic etiologies, a Fetal Heart Society Research Collaborative Study" American Heart Association Scientific Sessions (2024)
  • "Plenary Keynote Speaker" Cuban 8th Cardio-Oncology Symposium (2024)
  • "Management and Treatment Strategies for Cardiomyopathies in Children" Cardiogenetics Scientific Summit (2024)
  • "Management and Treatment Strategies for Cardiomyopathies in Children" Cardiogenetics Scientific Summit (2024)
  • "Cardiotoxicity After Childhood Cancer: Beginning with the End in Mind" Children's Hospital of Los Angeles Pediatric Grand Rounds (2024)
  • "Evaluating Children with Hypertrophic Cardiomyopathy: Importance of Cardiac MRI" Children’s Cardiomyopathy Foundation Webinar: Evaluating Children with Hypertrophic Cardiomyopathy: Importance of Cardiac MRI (2024)
  • "Pediatric Grand Rounds Speaker and Visiting Professor" Mayo Clinic (2024)
  • "Thomas Force Lecture" Global Cardio-Oncology Summit 2024 (2024)
  • "Pediatric Dilated Cardiomyopathy Update" Children’s Cardiomyopathy Foundation Webinar. Advances in Pediatric Cardiomyopathy-6th International Conference Highlights (2024)
  • "Founder, organizer, co-chair steering committee, co-chair planning committee" 6th International Conference on Cardiomyopathy in Children (2024)
  • "Management of Asymptomatic Dilated Cardiomyopathy" Sixth International Conference on Cardiomyopathy in Children (2024)
  • "Management of Asymptomatic Dilated Cardiomyopathy" 6th International Conference on Cardiomyopathy in Children (2024)
  • "Cardiac Late Effects: Update" NCI-Dana-Farber Childhood Cancer Investigator Meeting (2024)
  • "Cardiac Late Effects: Updates" Sallan All Investigators’ Meeting (2024)
  • "Keynote Lecturer" 2024 John A Burns School of Medicine Biomedical Sciences Symposium (2024)
  • "Management and Treatment Strategies for Cardiomyopathies in Children: Are Children Small Adults?" Grand Rounds - Hawai’i Pacific Health: Straub Medical Center, Honolulu, Hawaii (2024)
  • "Pediatric Cardiomyopathy Care Considerations" Children’s Cardiomyopathy Foundation - Experts on Pediatric Cardiomyopathy Educational Webinar Series (2024)
  • "Management and Treatment Strategies for Cardiomyopathies in Children" Children’s Cardiomyopathy Foundation Webinar (2024)
  • "Registry-Based Research for Pediatric Rare Diseases: The NIH Pediatric Cardiomyopathy Registry" Pediatric Grand Rounds; University at Buffalo (2021)
  • "Cardiotoxicity in Cancer Therapy" Pediatric Grand Rounds; University at Buffalo (2020)
  • "AML: Start as Oncology Patients, but Return with Heart Damage" Media Interview; Medscape (2020)
  • "Cutting-edge medical research is thriving in Western New York" Media Interview - Top Leading Medical Researcher; Buffalo News (2020)
  • "Values in the Making of the Environment: Implications for Child Health" Pediatric Grand Rounds; University at Buffalo (2019)
  • "Cardio-Oncology in Childhood Cancer" Population Sciences Grand Rounds; Roswell Park Comprehensive Cancer Center (2019)
  • "Pediatric Cardio-Oncology" Pediatric Oncology Survivorship Meeting; Sofia‘s Hope, Inc. (2019)
  • "Pediatric Cardio-Oncology Update" NCI ALL Consortium Meeting; Dana-Farber Cancer Institute/Harvard Medical School (2019)
  • "Cardio-Oncology in Pediatric Surgery Patients" Surgery Grand Rounds; University at Buffalo (2019)
  • "Special Lecture: Prevention in Cardio-Oncology. How to Mitigate Cardiotoxicity – Role of Exercise, Statin and Cardioprotective Agents. Lessons Learned From Survivors of Childhood Cancer" 4th Cardio-Oncology Symposium - A Comprehensive Approach to Cardiovascular Health and Disease During and After Cancer: A Case Based Curriculum; Memorial Sloan Kettering Cancer Center (2019)
  • "Beginning with the End in Mind: Cardiotoxicity after Childhood Cancer" Pediatric Grand Rounds; Washington University in St. Louis; Visiting Professor (2019)
  • "Childhood Obesity" Pediatric Research Conference; University at Buffalo (2019)
  • "Early Signs of Adult Onset Cardiovascular Disease in the Young" 22nd Annual Update on Pediatric and Congenital Cardiovascular Disease Conference; Children‘s Hospital of Philadelphia (2019)
  • "How Does the Heart Fail I: Primary Cardiomyopathies in Children" 22nd Annual Update on Pediatric and Congenital Cardiovascular Disease Conference; Children‘s Hospital of Philadelphia (2019)
  • "The Challenges and Solutions of Right-sided Heart Failure" 22nd Annual Update on Pediatric and Congenital Cardiovascular Disease Conference; Children‘s Hospital of Philadelphia (2019)
  • "Cardio-Oncology Issues in Patients with Osteosarcoma" FACTOR 2019; Make It Better for Kids with Osteosarcoma (MIB) Agents (2019)
  • "Pediatric Hypertrophic Cardiomyopathy Research and Grant" Pediatric Cardiomyopathy Registry Retreat; American Dental Association; Keynote Speaker and Organizer (2018)
  • "Q & A" Symposium: "Cardioprotection and the Role of Cardioxane"; Clinigen Group PLC (2018)
  • "Who Needs Cardioprotection?" Symposium: "Cardioprotection and the Role of Cardioxane"; Clinigen Group PLC (2018)
  • "Beginning with the End in Mind: Cardiotoxicity after Childhood Cancer" Pediatric Grand Rounds; Duke University; Paige Anderson Annual Lecturer and Visiting Professor (2018)
  • "Pediatric Cardio-Oncology" Annual Meeting; Sofia‘s Hope, Inc. (2018)
  • "Pediatric Cardio-Oncology Update" NCI Childhood ALL International Annual Investigator Meeting; Dana-Farber Cancer Institute/Harvard Medical School (2018)
  • "Cardiometabolic Risk in Childhood Cancer Survivors: A Children’s Oncology Group Study" Annual Meeting; American Society of Clinical Oncology (2018)
  • "Long-Term Cardioprotective Effects of Dexrazoxane Infusion During Anthracycline Chemotherapy: A Children’s Oncology Group Speckle Echocardiography Study" 29th Annual Scientific Sessions; American Society of Echocardiography (2018)
  • "A Randomized Clinical Trial on the Long-Term Effects of Methylphenidate on Cardiovascular Function and Structure in Rhesus Monkeys" Annual Meeting; Pediatric Academic Societies; Heart Failure Miscellaneous (2018)
  • "Are Echocardiogram and Magnetic Resonance Imaging (MRI) Comparable in Measuring Maximal Septal Thickness in Children with Hypertrophic Cardiomyopathy (HCM)?" Annual Meeting; Pediatric Academic Societies; Cardiology Imaging (2018)
  • "Cardiac and Inflammatory Biomarkers in Perinatally HIV-Infected and HIV-Exposed Uninfected Children" Annual Meeting; Pediatric Academic Societies; Heart Failure Miscellaneous (2018)
  • "Cardiac Biomarkers are Associated with Death and Listing for Heart Transplantation in Pediatric Patients with Newly Diagnosed Dilated Cardiomyopathy: A Multi-Center Study from the Pediatric Cardiomyopathy Registry" Annual Meeting; Pediatric Academic Societies; Myocardial and Coronary Diseases (2018)
  • "Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART 2 Study" Annual Meeting; Pediatric Academic Societies; Myocardial and Coronary Diseases (2018)
  • "Cardiovascular Signaling Proteins as Predictors of Doxorubicin-Related Cardiac Effects in Children with Acute Lymphoblastic Leukemia" Annual Meeting; Pediatric Academic Societies; Heart Failure Miscellaneous (2018)
  • "Fibrosis and Hypertrophy Assessed by Magnetic Resonance Imaging (MRI) and Serum Biomarkers in Pediatric Hypertrophic Cardiomyopathy (HCM). A Report from the Pediatric Cardiomyopathy Registry Group" Annual Meeting; Pediatric Academic Societies; Myocardial and Coronary Diseases (2018)
  • "Pediatric Cardio-Oncology" Joint Clinical and Translational Cardiology Conference; Chinese University of Hong Kong/University of Hong Kong/Karolinska Institutet (2018)
  • "Prevention in Cardio-Oncology. How to Mitigate Cardiotoxicity - Role of Exercise, Statin and Cardioprotective Agents. Lessons Learned From Survivors of Childhood Cancer" 3rd Cardio-Oncology Symposium - “A Comprehensive Approach to Cardiovascular Health and Disease During and After Cancer: A Case Based Curriculum"; Memorial Sloan Kettering Cancer Center (2018)
  • "Revising Clinical Genetic Panel Test Results for Pediatric Cardiomyopathy After Exome Sequencing" Annual Meeting; Pediatric Academic Societies; Myocardial and Coronary Diseases (2018)
  • "A Randomized Clinical Trial on the Long-Term Effects of Methylphenidate on Cardiovascular Function and Structure in Rhesus Monkeys" 67th Annual Scientific Session & Expo; American College of Cardiology (2018)
  • "Biomarker in Pediatric Heart Failure" Sumner J. Yaffe Memorial Lecture Series; Eunice Kennedy Shriver National Institute of Child Health and Health Development (2018)
  • "Cardiac and Inflammatory Biomarkers in Perinatally HIV-Infected and HIV-Exposed Uninfected Children" 67th Annual Scientific Session & Expo; American College of Cardiology (2018)
  • "Cardiotoxicity in Children: From Anthracyclines to Novel Targeted Agents" Advances in Pediatric Heart Failure: Congenital Disease and Cardiomyopathies; Foundazione Menarini; Session IV: Emerging Topics (2018)
  • "Cardiovascular Signaling Proteins as Predictors of Doxorubicin-Related Cardiac Effects in Children with Acute Lymphoblastic Leukemia" 67th Annual Scientific Session & Expo; American College of Cardiology (2018)
  • "The Frequency of Mutations in Known Cardiomyopathy Genes Among Children with Hypertrophic Cardiomyopathy: The National Heart, Lung and Blood Institute-Funded Multicenter Pediatric Cardiomyopathy Registry Study" 67th Annual Scientific Session & Expo; American College of Cardiology (2018)
  • "Pediatric Cardiomyopathies" International Stroke Conference; American Heart Association; Bugher Symposium (2018)
  • "Are Echocardiogram and Magnetic Resonance Imaging (MRI) Comparable in Measuring Maximal Septal Thickness in Children with Hypertrophic Cardiomyopathy (HCM)?" Scientific Sessions; American Heart Association; Heart Failure and Cardiomyopathies: General Topics III (2017)
  • "Cardiac Biomarkers are Associated with Death and Listing for Heart Transplantation in Pediatric Patients With Newly Diagnosed Dilated Cardiomyopathy: A Multi-Center Study from the Pediatric Cardiomyopathy Registry" Scientific Sessions; American Heart Association; Heart Failure: Pathophysiology & Diagnosis II (2017)
  • "Cardioprotection in Elderly Patients" Annual Conference; International Society of Geriatric Oncology (2017)
  • "Exome Sequencing in a Pediatric Cardiomyopathy Cohort: Findings from the Pediatric Cardiomyopathy Registry" Scientific Sessions; American Heart Association; Genetic Mechanisms of Cardiomyopathies and Arrhythmias (2017)
  • "Fibrosis and Hypertrophy Assessed by Magnetic Resonance Imaging (MRI) and Serum Biomarkers in Pediatric Hypertrophic Cardiomyopathy (HCM). A Report from the Pediatric Cardiomyopathy Registry Group" Scientific Sessions; American Heart Association; Novel insights into the Diagnosis and Prognosis of Cardiomyopathy and Heart Failure (2017)
  • "Re-Evaluating the Role of Dexrazoxane" Advisory Board Meeting; Clinigen (2017)
  • "The Gaps and Challenges in Identifying Cardiovascular Liabilities from the Clinical Perspective" FDA Public Workshop: Improving Cardiotoxicity Assessment with Human-Relevant Platforms; National Center for Toxicological Research (2017)
  • "Cardio-oncology" CME Program; St. Joseph‘s Regional Medical Center (2017)
  • "Cardio-oncology" Children‘s Oncology Group Fall Group Meeting; National Cancer Institute; Acute Myeloid Leukemia and ALTE11C2 (2017)
  • "The Pediatric Cardiomyopathy Registry: The Role of Registries in Informing Design of Pediatric Clinical Trials" "Drug Development in Pediatric Heart Failure: Extrapolation, Clinical Trial Design and Endpoints" Workshop; Food and Drug Administration (2017)
  • "The Use of Dexrazoxane as a Cardioprotective Agent in Paediatric Patients" Global Cardio-Oncology Meeting; Royal College of Physicians; Lunchtime Symposium on Cardioprotection (2017)
  • "Caffeinated Energy Drink Health Effects in Pediatric Populations: A Decade’s Journey" Pediatric Grand Rounds; Wayne State University/Children‘s Hospital of Michigan (2017)
  • "Cardio-oncology Updates" Leukemia Consortium Investigator Meeting; Dana Farber Cancer Institute (2017)
  • "Beginning with the End in Mind: Cardiotoxicity After Childhood Cancer" Pediatric Grand Rounds; University of Washington (2017)
  • "Oncocardiology in Sarcoma Survivorship" Annual Meeting; American Society of Clinical Oncology; Survivorship in Pediatric and Adult Patients with Sarcoma Education Session (2017)
  • "The Quest to Improve Cancer Therapy while Minimizing Cardiotoxicity" Medicine Grand Rounds/Cardio-oncology Symposium; Memorial Sloan Kettering Cancer Center (2017)
  • "Beginning with the End in Mind: Cardiotoxicity After Childhood Cancer" Academy of Scholars; Wayne State University (2017)
  • "Are There Solutions - Efforts to Mitigate and Manage Cancer Drug-Related Toxicities" Annual Meeting; Society of Toxicology; Enhancing the Clinical Benefit of Cancer Drugs: Toxicity as a Therapeutic Target Scientific Symposium (2017)
  • "No One Should be Started on an ACE-Inhibitor or Angiotensin Receptor Blocker to Mitigate Cardiomyopathy with Cancer Therapy" Annual Scientific Session; American College of Cardiology; Heart Failure and Cancer Care (2017)
  • "Childhood Cancer Cardiotoxicity: Beginning with the End in Mind" 2nd International Meeting on CardiOncology; International Society of Cardio Oncology (2017)
  • "Towards a Comprehensive Cardiac-Cancer Care" 2nd International Meeting on CardiOncology; International Society of Cardio Oncology (2017)
  • "Childhood Cardiotoxicity" 4th International Conference on Cancer and the Heart; University of Texas MD Anderson Cancer Center (2016)
  • "Spectrum of Gene Mutations in Pediatric Hypertrophic Cardiomyopathy" Scientific Sessions; American Heart Association; Heart Failure: Type of Heart Disease (2016)
  • "Registry-Based Research: The Pediatric Cardiomyopathy Registry" Pediatric Grand Rounds; University of Tennessee School of Medicine (2016)
  • "Values in the Making of the Environment: Implications for Child Health" Pediatric Grand Rounds; Children's Hospital of Michigan (2016)
  • "Cardiovascular Morbidity and Mortality After Pediatric Organ Transplantation: Etiology and Management with Special Focus on the Role of the Cardiologist" Annual Meeting; International Pediatric Nephrology Association; Long-Term Complications Following Renal Transplantation Special Symposium (2016)
  • "Pediatric Survivors: Monitoring and Prevention Strategies of Cardiovascular Toxicities" Cardiovascular Toxicity Assessment in Oncology Trials Workshop; Food and Drug Administration; Monitoring and Prevention Session (2016)
  • "Registry-Based Research: The Pediatric Cardiomyopathy Registry" Pediatric Grand Rounds; University of Pittsburgh/Children‘s Hospital of Pittsburgh of UPMC (2016)
  • "Cardiac Effects of Childhood Cancer Treatment: Improvements Over the Last Five Years" 5th Annual Childhood Cancer Survivorship Symposium; Leukemia and Lymphoma Society (2016)
  • "Energy Drink Health Effects in Children" 14th Annual Pediatric Scholarly Presentation Day; University of Toledo (2016)
  • "Quality of Life and Functional Status with Cancer" International Symposium on Kids Kicking Cancer (2016)
  • "Cardiovascular Disease in Adult Survivors of Childhood Cancer" Cardiotoxicity and Pediatric Oncology Meeting; German Pediatric Cardiology Society (2016)
  • "Childhood Cancer Cardiotoxicity: Beginning with the End in Mind" Cardiology Grand Rounds; Massachusetts General Hospital/Harvard Medical School (2016)
  • "Doxorubicin Cardiomyopathy: Mechanisms and Therapeutic Targets" Cardiotoxicity and Pediatric Oncology Meeting; German Society of Pediatric Cardiology (2016)
  • "Late Cardiovascular Effects of Cancer Therapy in Childhood" Cardiotoxicity and Pediatric Oncology Meeting; German Society of Pediatric Cardiology (2016)
  • "The Effect of Environmental Exposures on Cardiovascular Structure and Function in Children" Seminar Series; Institute of Environmental Health Sciences/Center for Urban Responses to Environmental Stressors (2016)
  • "Cardiotoxicity of Anti-Tumour Compounds" Pharmacology 2015; British Society for Cardiovascular Research/British Pharmacological Society; Targeting Cardiotoxicity Symposium (2015)
  • "Heart Failure After Chemotherapy: Prevention and Treatment Strategies" Innovations in Pediatric Heart Failure Symposium; Rady Children‘s Hospital Heart Institute/University of California, San Diego; Heart Failure in Cardiomyopathy Patients Session (2015)
  • "Cardiac Biomarkers in Kidney Diseases" Physiology Seminar Series; Wayne State University (2015)
  • "Cardiovascular Toxicity in Paediatric Cancer Treatment" 2015 Cancer Conference; National Cancer Research Institute; Cardiovascular Toxicity in Paediatric Cancer Treatment Session (2015)
  • "Results of Research Genetic Testing in Pediatric Cardiomyopathy Patients Justify Broader Clinical Genetic Testing" Scientific Sessions; American Heart Association; Cardiomyopathies (2015)
  • "The Association of Growth Patterns and Clinical Outcomes in Children with Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group" Scientific Sessions; American Heart Association; Pediatric Heart Failure and Transplant in All Forms, Shapes, and Sizes (2015)
  • "Lessons Learned from the Pediatric Cardiomyopathy Registry" "Affairs of the Heart: Living with Genetic Cardiomyopathy" Conference; SHaRe Cardiomyopathy Registry (2015)
  • "Pediatric Research Studies and Registries" "Affairs of the Heart: Living with Genetic Cardiomyopathy" Conference; SHaRe Cardiomyopathy Registry (2015)
  • "Childhood Cancer Cardiotoxicity: Beginning with the End in Mind" Pediatric Grand Rounds; Kravis Children’s Hospital/Icahn School of Medicine at Mount Sinai (2015)
  • "Lessons Learned from the Pediatric Cardiomyopathy Registry" Pediatric Heart Center Grand Rounds; Kravis Children’s Hospital/Icahn School of Medicine at Mount Sinai (2015)
  • "Long-Term Survivors of Childhood Cancer: Cardio-oncology" Symposia on Survivorship; Children's Hematology Alliance of Michigan (2015)
  • "The Importance of Research to Improve Outcomes at Children’s Hospitals" Raise the Beam Ceremony; Children‘s Hospital of Michigan (2015)
  • "Cardio-oncology: Cardiac Complications in Survivors of Childhood Cancer" Pediatric Grand Rounds; Case Western Reserve University/Rainbow Babies and Children's Hospital (2015)
  • "Non-Cancer Outcomes from Radiation Exposure" Radiation Epidemiology and Dosimetry Course; National Institutes of Health; Radiation Epidemiology Branch (2015)
  • "CardioOncology: Cardiac Complications in Survivors of Childhood Cancer" Pediatric Hematology/Oncology Grand Rounds; Doernbecher Children's Hospital (2015)
  • "Lessons Learned from the Pediatric Cardiomyopathy Registry Study Group" Pediatric Grand Rounds; Wayne State University/Children‘s Hospital of Michigan (2015)
  • "Lessons Learned from the Pediatric Cardiomyopathy Registry Study Group" Cardiovascular Research and Genetics Center Programs Grand Rounds; Regeneron Pharmaceuticals (2015)
  • "Lessons Learned from the Pediatric Cardiomyopathy Registry Study Group" Center for Molecular Medicine and Genetics; Wayne State University (2015)
  • "CardioOncology: Cardiac Complications in Survivors of Childhood Cancer" 15th International Symposium on Congenital Heart Disease; Johns Hopkins All Children’s Heart Institute; Session 3: Chronic Heart Failure (2015)
  • "Childhood Cancer Cardiotoxicity: Beginning with the End in Mind" 1st International Meeting on CardiOncology; International Society of Cardio Oncology (2015)
  • "Late Cardiovascular Effects Years After Radiation Exposures: Being Preemptive Rather than Reactive" Annual Joint Meeting; CEREBRAD/PROCARDIO; Student‘s Day (2015)
  • "Lessons Learned from the Pediatric Cardiomyopathy Registry Study Group" 15th International Symposium on Congenital Heart Disease; Johns Hopkins All Children’s Heart Institute (2015)
  • "Towards a Comprehensive Cardiac-Cancer Care" 1st International Meeting on CardiOncology; International Society of Cardio Oncology (2015)
  • "Onco-Cardiology" Visiting Professor Lecture Series; Children‘s Hospital of Orange County; Heart Institute and Division of Oncology (2015)
  • "Optimizing Lifespan Health in the Transition from a Potentially Fatal Childhood Illness to Effective Chronic Disease Management: The Role of Gene-Based Personalized Cardioprotection in the Cardiotoxicity with Childhood Cancer Story" Pediatric Grand Rounds; Oakland University William Beaumont School of Medicine (2015)
  • "Cardiotoxicity After Childhood Cancer: Beginning with the End in Mind" Cardiology Grand Rounds; Dartmouth Hitchcock Medical Center (2014)
  • "Late Cardiovascular Effects Years After Radiation Exposures: Being Preemptive Rather than Reactive" Medicine and Pediatric Grand Rounds; Dartmouth-Hitchcock Heart & Vascular Center (2014)
  • "Cardiotoxicities" 4th Annual Transatlantic in Oncology Meeting; Euromeds (2014)
  • "Energy Drink Exposures in the National Poison Data System: Epidemiology and Clinical Effects" Scientific Sessions; American Heart Association (2014)
  • "Grant Reviews" Medical Advisors Meeting; Children‘s Cardiomyopathy Foundation (2014)
  • "Improved Transplant-Free Survival of Children with Dilated Cardiomyopathy: Analysis of Two Decades from the Pediatric Cardiomyopathy Registry" Scientific Sessions; American Heart Association (2014)
  • "Mechanisms of Cardiotoxicity and Cardioprotection" Annual Meeting; Brazilian Society of Pediatric Oncology (2014)
  • "Presentation and Progression of Cardiovascular Toxicity" Scientific Sessions; American Heart Association; Cardiovascular Seminar (2014)
  • "Long Term Cardiac Consequences of Cancer Treatment in the Pediatric Population" Medicine Grand Rounds; University of Ottawa (2014)
  • "Cancer Survivorship and Heart Failure" Annual Meeting; Heart Failure Society; Heart Failure in Cancer Patients and Survivors Session (2014)
  • "Heart Failure in Cancer Patients" Pediatric Heart Failure Summit; Cincinnati Children’s Hospital Medical Center (2014)
  • "Optimizing Lifespan Health in the Transition from a Potentially Fatal Childhood Illness to Effective Chronic Disease Management: The Role of Gene-Based Personalized Cardioprotection in the Cardiotoxicity with Childhood Cancer Story" Pediatric Grand Rounds; Wayne State University (2014)
  • "Childhood Cancer and Cardiomyopathy" 3rd International Conference on Cardiomyopathy in Children; National Heart, Lung and Blood Institute (2014)
  • "How Much Do We Know about Long-Term Safety of Drugs in Children?" Annual Meeting; Pediatric Academic Societies; CTSA Consortium Child Health Oversight Committee Symposium (2014)
  • "Optimizing Lifespan Health in the Transition from a Potentially Fatal Childhood Illness to Effective Chronic Disease Management: The Role of Gene-Based Personalized Cardioprotection in the Cardiotoxicity with Childhood Cancer Story" 13th Annual Pediatric Research Day: New Frontiers in Pediatrics; Wayne State University/Children‘s Hospital of Michigan (2014)
  • "Pathophysiology, Clinical Course and Protection" International Colloquium on Cardio-Oncology; University Campus Bio-medico of Rome/Menarini Foundation (2014)
  • "Safety of Energy Drinks" Annual Session; Society of Toxicology (2014)
  • "Dexrazoxane in Childhood Cancer" "Prevention of Chemotherapy-Induced Cardiotoxicity" Cancer and Heart Workshop; University of Texas MD Anderson Cancer Center (2013)
  • "Echocardiographic Normalization in Children with Idiopathic Dilated Cardiomyopathy: Results from the Pediatric Cardiomyopathy Registry" Scientific Sessions; American Heart Association; Pediatric Heart Failure: Prognosis and Treatment from Infusion to Transplant Session (2013)
  • "Echocardiographic Normalization in Children with Idiopathic Dilated Cardiomyopathy: Results from the Pediatric Cardiomyopathy Registry" Scientific Sessions; American Heart Association (2013)
  • "The Legacy of Cardiovascular Disease for Cancer Survivors" Scientific Sessions; American Heart Association (2013)
  • "Cancer Cardiotoxicity. Challenges in Advanced Pediatric Heart Failure" Pediatric Heart Failure Summit; Texas Children‘s Hospital (2013)
  • "Cardiac HIV Disease" PHACS Fall Network Meeting; National Institutes of Health; Cardiopulmonary Working Group (2013)
  • "Cardiac Risk-Factors Analysis and Assessments for the Extended Prediction and Prevention of Cardiovascular Disease in Childhood Cancer Survivors Treated with and without Anthracyclines" XXXI National Congress of Oncology; Mexican Society of Oncology; Pediatric Oncology Session (2013)
  • "Cardioprotection Strategies During Cancer Treatment with Anthracyclines and Radiotherapy for Long-Term Prevention of Cardiotoxicity in Children With Cancer" XXXI National Congress of Oncology; Mexican Society of Oncology; Updates and Controversies in the Treatment of Children with Cancer Session (2013)
  • "Radiation-Associated Cardiovascular Effects" Annual Joint Meeting; CEREBRAD/PROCARDIO (2013)
  • "The Importance of Having a Clinic for Late Effects in Pediatric Oncology Hospitals" XXXI National Congress of Oncology; Mexican Society of Oncology (2013)
  • "Treatment of Symptomatic Cardiotoxicity and Cardiac Failure in Childhood Cancer Survivor Treated with Anthracyclines" XXXI National Congress of Oncology; Mexican Society of Oncology; The Current Problems in Long-Term Survivors of Childhood Cancer Session (2013)
  • "Beginning with the End in Mind: Cardiotoxicity After Childhood Cancer" Pediatric Grand Rounds; New York Medical College (2013)
  • "Cardiac Toxicities in Adolescents and Young Adult Cancer Survivors" Mechanisms of Accelerated Aging in Cancer Survivors Meeting; National Cancer Institute; Division of Cancer Control and Population Sciences (2013)
  • "Cardiomyopathy and Other Cardiovascular Effects Following Radiotherapy for Childhood Cancer" 59th Annual Meeting; Radiation Research Society (2013)
  • "PCMR: Risk Stratification at the Time Of Diagnosis for Children with Hypertrophic Cardiomyopathy: A Report from the PCMR Study Group" Congress; European Society of Cardiology; Registry Hot Line: Registries on Prevention and Treatment Session (2013)
  • "Personalized Cardioprotection" Progress Towards Individualised Cancer Treatment; Royal Society of Medicine (2013)
  • "Children as a Vulnerable Population for the Health Effects of Energy Drinks" Potential Health Hazards Associated with Consumption of Caffeine in Food and Dietary Supplements Workshop; Institute of Medicine; Exploring Safe Levels of Exposure for Vulnerable Population Groups (including dosage levels) Session (2013)
  • "Cardiac Studies Update" Sallan Summer Acute Lymphoblastic Leukemia Investigator Meeting; National Cancer Institute/Dana Farber Cancer Institute (2013)
  • "Onco Cardiology: Cardiovascular Complications of Cancer Treatment: ‘A Double-Edged Sword’" Adult Cardiology Grand Rounds; University of Miami Miller School of Medicine (2013)
  • "Biomarkers, Course, and Surrogate Endpoints in Pediatric Cardiomyopathy" Invited Presentation; Royal Children‘s Hospital/Murdoch Children‘s Research Institute (2013)
  • "Cardiac Biomarkers in Kidney Diseases" Invited Presentation; Royal Children‘s Hospital/Murdoch Children‘s Research Institute (2013)
  • "Optimizing Lifespan Health in the Transition from a Potentially Fatal Childhood Illness to Effective Chronic Disease Management: The Cardiotoxicity with Childhood Cancer Story" Pediatric Grand Rounds; Royal Children's Hospital/Murdoch Children's Research Institute (2013)
  • "Radiation Associated Cardiovascular Effects" Invited Presentation; Royal Children‘s Hospital/Murdoch Children‘s Research Institute (2013)
  • "Setting-Up a Pediatric Cardiomyopathy Registry" Invited Presentation; Royal Children‘s Hospital/Murdoch Children‘s Research Institute (2013)
  • "The Early Origins of Lifespan Health and Disease Related to Childhood Obesity: Beginning with the End in Mind" Invited Presentation; Royal Children‘s Hospital/Murdoch Children‘s Research Institute (2013)
  • "Cardiomyopathy Following Radiation Exposure in the Childhood Cancer Survivor Cohort" Radiation and Cardiovascular Disease Conference; Radiation Effects Research Foundation (2013)
  • "The Early Origins of Lifespan Health and Disease Related to Childhood Obesity: Beginning with the End in Mind" Basic, Clinical and Translational Science of Obesity Symposium; University of Miami; CTSI Collaborative Research Exchange Forum (2013)
  • "Optimizing Lifespan Health in the Transition from a Potentially Fatal Childhood Illness to Effective Chronic Disease Management: The Cardiotoxicity with Childhood Cancer Story" Pediatric Grand Rounds; University of Maryland School of Medicine (2013)
  • "Cardiotoxicity After Cancer" Cardiology and Oncology Grand Rounds; LDS Hospital; Intermountain Blood and Marrow Transplant Program (2012)
  • "Cardiotoxicity of the Pediatric Patient, Chemical Cardioprotection in Children, and Long-Term Follow-Up of the Pediatric Patient" 2nd International Conference on Cancer and the Heart; American Society of Clinical Oncology (2012)
  • "Optimizing Lifespan Health in the Transition from a Potentially Fatal Childhood Illness to Effective Chronic Disease Management: The Cardiotoxicity with Childhood Cancer Story" Department of Quantitative Health Sciences Special Conference; University of Massachusetts Medical School (2012)
  • "Pediatric Cardiomyopathy" Pediatric Grand Rounds; University of Florida (2012)
  • "Cardioprotection" Annual Meeting; Mexican Society of Oncology; Cardioprotection Symposium (2012)
  • "Clinical Perspective: How Are We Doing from a Clinician’s Point of View?" Annual Meeting; Safety Pharmacology Society (2012)
  • "Radiation-Associated Cardiovascular Effects" Annual Joint Meeting; CEREBRAD/PROCARDIO (2012)
  • "How Can We Best Avoid Heart Failure After Chemotherapy?" Pediatric Heart Failure Summit; Hospital for Sick Children (2012)
  • "What Exactly Does a Community Paediatrician Need to Know about Cardiovascular Risk Factors of Obese Children - Aetiology and Management?" Annual Conference; Canadian Pediatric Society; Children's Health Foundation: Childhood Obesity Luncheon (2012)
  • "Cardiotoxicity with Childhood Cancer" Cancer Prevention and Control Seminar; St. Jude Children’s Research Hospital (2012)
  • "Anthracycline Cardiotoxicity in Pediatric Oncology" Brazilian Congress on Pediatric Oncology; Brazilian Society of Pediatric Oncology (2012)
  • "Cardiovascular Effects of Radiation Exposures" Radiation Oncology Grand Rounds; University of Miami Miller School of Medicine (2012)
  • "Radiation Cardiotoxicity" Brazilian Congress on Pediatric Oncology; Brazilian Society of Pediatric Oncology; Cardio-oncology in Pediatrics Symposium (2012)
  • "Cardiac Biomarkers in Kidney Diseases" Pediatric Nephrology Seminar XXXIX; University of Miami; Hypertension and Vascular Biology Session (2012)
  • "Long-Term Medical Issues for Childhood Cancer Survivors and Survivorship Planning" Childhood Cancer Survivorship: The Past and The Future Symposia; Leukemia and Lymphoma Society (2012)
  • "Cancer Cardiotoxicity" Annual Scientific Meeting; Women's Cancer Association (2012)
  • "Biomarkers, Course, and Surrogate Endpoints in Pediatric Cardiomyopathy" Clinical and Translational Seminar Series; University of Miami (2012)
  • "The Changing Scope of Federal Research Funding-Clinical Effectiveness" Otolaryngology Grand Rounds; University of Miami Miller School of Medicine (2012)
  • "Biomarkers in Pediatric Cardiomyopathy" Pediatric Grand Rounds; Columbia University College of Physicians and Surgeons (2011)
  • "Proposal for Follow-Up of AMP Subjects After Initial Cardiac Echo" PHACS Cardiology Task Force Retreat; National Institutes of Health (2011)
  • "Review and Interpretation of Echocardiogram Data in HIV-Infected Subjects (AMP)" PHACS Cardiology Task Force Retreat; National Institutes of Health (2011)
  • "Cardiac Fibrosis - Current State and Future Perspectives" Global Fibrosis Meeting; Hoffman-La Roche Corporation (2011)
  • "Beyond Cholesterol: Preventive Pediatric Cardiology" Housestaff Conference; Comer Children's Hospital (2011)
  • "Childhood Cancer Cardiotoxicity" Annual Pediatric Research Day; University of Chicago/Comer Children's Hospital (2011)
  • "Comparison of Late Cardiovascular Risk After Radiation Exposure and After Treatment with Anti-Cancer Drugs" CARDIORISK (Mechanisms of Cardiovascular Risk After Low Radiation Doses) Symposium; European Commission (2011)
  • "Where are There Opportunities to Reduce Cardiovascular Related Attrition and Improve Cardiovascular Safety?" Annual Plenary Session; Health and Environmental Sciences Institute/Cardiac Safety Research Consortium (2011)
  • "Childhood Cancer Cardiotoxicity" 2nd Annual Mary Allen Engle Visiting Lecture; Weill Cornell University Medical College/New York-Presbyterian Phyllis and David Komansky Center for Children’s Health (2011)
  • "Philanthropy in Pediatric Departments" Annual Meeting; Association of Medical School Pediatric Department Chairs (2011)
  • "Cardiotoxicity with Childhood Cancer" Molecular and Cellular Pharmacology Grand Rounds; University of Miami Miller School of Medicine (2011)
  • "Cardiotoxicity with Childhood Cancer" Pediatric Grand Rounds; Yale School of Medicine (2011)
  • "Ongoing Trials-Cardiomyopathy Registry" Duchenne Muscular Dystrophy Research Network Workshop; Muscular Dystrophy Association (2011)
  • "Cardiotoxicity with Childhood Cancer" Pediatric Grand Rounds; City of Hope Comprehensive Cancer Center (2010)
  • "Radiation-Induced Cardiovascular Injury Compared to Chemotherapy-Induced Cardiac Toxicity" Exploratory Workshop on Radiation-Induced Vascular Effects Resulting from Low Dose Exposure-a Consensus Conference; DoReMi; Functional and Clinical Studies in Humans Session (2010)
  • "Beyond Cholesterol: Pediatric Cardiovascular Disease Prevention" Adult Cardiology Grand Rounds; University of Miami Hospital (2010)
  • "Cardiomyopathy After Childhood Cancer" Visiting Professor Lecture; Tokyo Women's Medical University (2010)
  • "Cardiomyopathy Following Treatment of Childhood Cancer" Scientific Sessions; American Heart Association; Cardiomyopathies 2010: Looking Beyond the Sarcomere (2010)
  • "Setting-Up a Pediatric Cardiomyopathy Registry" Annual Meeting; Japanese Society for Pediatric Cardiology and Cardiac Surgery; Pediatric Cardiomyopathies Session (2010)
  • "Cardiomyopathies in Childhood" Cardiology Grand Rounds; University of Connecticut Health Center (2010)
  • "Cardiotoxicity After Childhood Cancer" Pediatric Grand Rounds; Connecticut Children's Medical Center (2010)
  • "Pediatric Cardiovascular Disease Prevention" Cardiometabolic Health Congress (2010)
  • "Cardiomyocyte Injury and Protection" 3rd Annual Symposium on Cardiac Development; Riley Heart Research Center (2010)
  • "Developmental Pathophysiology of CVD" Pediatric Sleep Disturbances and Their Contribution to Developmental Pathophysiology of Cardiometabolic Risk Workshop; National Heart, Lung and Blood Institute; Mechanisms of Cardiovascular Risk Arising from Sleep-Disordered Breathing and Short Sleep Session (2010)
  • "Beginning with the End in Mind: Cardiotoxicity After Childhood Cancer" Cardiovascular Research Symposium; University of Miami (2010)
  • "Global Burden of Cardiomyopathy" Scientific Sessions; World Congress of Cardiology; Global Burden of CVD: Part 2 Session (2010)
  • "Track 4: Anti Cancer Drug Discovery and Development" 3rd World Cancer Congress: Health Science without Borders; BIT Life Sciences (2010)
  • "Cardiotoxicity in Childhood Cancer Survivors" Emerging Issues in Pediatric Cancer Epidemiology; Texas Children's Cancer Center; Molecular Epidemiology Research in Pediatric Cancer Epidemiology and Late Effects Session (2010)
  • "Pediatric Cardiomyopathy Registry" 2nd International Conference on Pediatric Cardiomyopathy; National Heart, Lung and Blood Institute/Children‘s Cardiomyopathy Foundation (2010)
  • "Adverse Events from in utero ART Exposures" PHACS Semi-Annual Meeting; National Institutes of Health (2010)
  • "Cardiovascular Safety Pharmacology in Childhood Cancer" Seminar; Roche Corporation (2010)
  • "Beyond Cholesterol: Reducing the Risk for Premature Heart Disease" From Concept to Cure – A National Physicians’ Council Program; Hadassah Medical Organization (2010)
  • "Cancer Survivorship-Hope and Cure" Team in Training Program; Leukemia and Lymphoma Society (2010)
  • "Late Cardiovascular Effects of Childhood Cancer" From Concept to Care - A National Physicians' Council Program; Hadassah Medical Organization (2010)
  • "Beginning with the End in Mind - Avoiding Late Effects After Childhood Cancer" Annual Education Day; Women’s Cancer Association (2010)
  • "Beyond Cholesterol: Reducing the Risk for Premature Heart Disease" Labatt Children’s Heart Center; Hospital for Sick Children (2010)
  • "Cardiotoxicity After Childhood Cancer: Beginning with the End in Mind" Pediatric Oncology Society of Ontario Lecture; Hospital for Sick Children (2010)
  • "Cardiotoxicity After Childhood Cancer: Beginning with the End in Mind" Pediatric Grand Rounds; McMaster University (2010)
  • "Cardiovascular Safety Pharmacology, Troponin and Oncology" Cardiovascular Safety Pharmacology Seminar; Roche Corporation (2010)
  • "Diagnosis and Management of Cardiomyopathies in Children" Evolving Concepts in the Management of Congenital Heart Disease Symposium; Rady Children's Hospital/University of California, San Diego (2010)
  • "Radiation-Associated Cardiovascular Toxicity" Department of Pediatric Oncology; Hospital for Sick Children (2010)
  • "Cardiovascular Disease Risk Assessment and Diagnosis in HIV Infection" Initiative to Decreased Cardiovascular Risk and Increase Quality of Care for Patients Living with HIV/AIDS Conference; American Heart Association (2009)
  • "Late Cardiovascular Effects of Childhood Cancer" Robert Freedom Lecture; Hospital for Sick Children (2009)
  • "What Have We Learned from the Paediatric Cardiomyopathy Registry?" 4th Toronto Symposium in Pediatric Cardiology (2009)
  • "Cardiovascular Abnormalities of Children Born to HIV-Infected Women: The Role of Antiretroviral Therapy" Conference on Mechanisms and Management of Cardiovascular and Metabolic Complications of HIV/AIDS; National Institutes of Health (2009)
  • "Anthracycline Cardiomyopathy" Paediatric Cardiomyopathy Specialty Meeting; 5th World Congress of Paediatric Cardiology and Cardiac Surgery (2009)
  • "What Have We Learned from Registries - PCMR" Paediatric Cardiomyopathy Specialty Meeting; 5th World Congress of Paediatric Cardiology and Cardiac Surgery (2009)
  • "Beyond Cholesterol: Reducing the Risk for Premature Heart Disease" Pediatric Grand Rounds; Chris Evert Children’s Hospital (2009)
  • "Antiretroviral Cardiac Disease in Children" Annual Scientific Session; American College of Cardiology; HIV-Associated Cardiovascular Disease Educational Session (2009)
  • "Cardiac Evaluation of the Child with Chronic Kidney Disease" 36th Pediatric Nephrology Seminar; University of Miami Miller School of Medicine (2009)
  • "Anthracycline Related Cardiotoxicity" Pediatric Oncology Branch Research Seminar; National Cancer Institute (2009)
  • "Cardiotoxicity in Cancer" Cardiology Branch; National Heart, Lung and Blood Institute (2009)
  • "Energy Drinks for Children - Are They Safe? Should They be Banned? What is the Current Raging Controversy?" Masters of Pediatrics Conference; University of Miami (2009)
  • "Obtaining an Echocardiogram for a Pediatrician’s Concern about Cardiovascular Disease Does Not Need a Cardiology Consult vs. Every Echocardiogram for a Pediatrician’s Concern about Cardiovascular Disease Should Have a Cardiology Consult" Masters of Pediatrics Conference; University of Miami (2009)
  • "Beyond Cholesterol: Reducing the Risk for Premature Heart Disease" Pediatric Grand Rounds; University of South Florida School of Medicine (2008)
  • "Late Cardiotoxicity After Childhood Cancer" Pediatric Grand Rounds; Robert Wood Johnson Medical School (2008)
  • "Late Cardiovascular Effects of Childhood Cancer" Pediatric Grand Rounds; All Children’s Hospital (2008)
  • "Cardiac Problems in Children Born to HIV-Infected Mothers: The ART Effect" PHACS Semi-Annual Meeting; National Institutes of Health (2008)
  • "Current Status and Future Directions of the NHLBI PCMR Study" National Investigator Meeting; NHLBI Pediatric Cardiomyopathy Registry (2008)
  • "Pediatric HIV and Atherosclerotic Risk" Conference on Mechanisms and Management of Cardiovascular and Metabolic Complications of HIV/AIDS; National Heart, Lung and Blood Institute (2008)
  • "The Florida National Children’s Study Center" National Children’s Study Federal Advisory Committee Meeting and National Children’s Study Investigator Meeting; Eunice Kennedy Shriver National Institute of Child Health and Health Development (2008)
  • "The Importance of Child Health Research" Micah Batchelor Award Dinner; University of Miami (2008)
  • "CHAART Systolic Function Analyses" CHAART-1 Study National Investigator Meeting; National Heart, Lung and Blood Institute (2008)
  • "Current Status of the Pediatric Cardiomyopathy Registry" Pediatric Cardiomyopathy Registry National Investigator Meeting; National Heart, Lung and Blood Institute (2008)
  • "Preclinical Academic View" Cardiac Safety “Hot Topics” Thinktank Annual Meeting; CSRC/HESI/FDA; Cardiotoxicity and Troponin: Where Do They Fit in Drug Development Session (2008)
  • "Prevention of Cardiovascular Morbidity and Mortality in Children With Chronic Kidney Failure" 7th Annual Conference on Prevention in Renal Disease; ; Prevention in the Pediatric Patient Session (2008)
  • "The Power of Patient Registries for Rare Diseases: Experiences from the Pediatric Cardiomyopathy Registry and Their Relevance to Patients with Barth Syndrome and Their Families" 4th International Scientific, Medical and Family Conference; Barth Syndrome Foundation (2008)
  • "Beyond Cholesterol: Reducing the Risk for Premature Heart Disease" 7th Annual Pediatric Symposium: A Multispecialty Approach to Pediatric Care; Baptist Children's Hospital (2008)
  • "Chemotherapy-Associated Cardiotoxicity" The Scientific Basis of Heart Failure in Children Conference; American Heart Association/National Institutes of Health; Clinical Science of Pediatric Heart Failure: Evidence-Based Treatment of Acute Heart Failure Session (2008)
  • "Childhood Cancer Cardiotoxicity - From Prevention to Late Effects" 50th Annual Installation and Grant Distribution Luncheon; Women’s Cancer Association (2008)
  • "Late Cardiovascular Effects of Childhood Cancer" 7th Annual Pediatric Symposium: A Multispecialty Approach to Pediatric Care; Baptist Children's Hospital (2008)
  • "Monitoring Methods and Standards for Cardiac Dysfunction" 44th Annual Meeting; American Society of Clinical Oncology; Prevention and Screening of Treatment Related Cardiac Abnormalities in Survivors of Childhood Cancer Educational Session (2008)
  • "Beyond Cholesterol: Reducing the Risk for Premature Heart Disease" Annual Pediatric Update; Children’s Hospital Medical Center of Akron/Northeastern Ohio Universities College of Medicine (2008)
  • "Children’s Health Services" Board of Governors Strategic Retreat; University of Miami Medical Group (2008)
  • "Late Cardiovascular Effects of Childhood Cancer" Annual Pediatric Update; Children's Hospital Medical Center of Akron/Northeastern Ohio Universities College of Medicine (2008)
  • "Raising Healthy Children and Proactive Parents: Connecting the Science to Meaningful Choices for Parents" South Florida Community Educational Conference; University of Miami Sylvester Comprehensive Cancer Center (2008)
  • "Cardiac Status of 1- and 2-Year-Old HIV-1-Uninfected Children Born to HIV-1-Infected Mothers Receiving NRTIs Therapy During Pregnancy" Annual Meeting; Society of Toxicology; Perinatal Exposure to Nucleoside Reverse Transcriptase Inhibitors Induces Transplancental Genotoxicity and Mitochondrial Toxicity Symposium (2008)
  • "Cardiovascular Disease and Visions of Interdisciplinary Training, Research and Patient Care" University of Miami Cardiovascular Research Symposium; NHLBI Training Program in Cardiovascular Signaling (2008)
  • "Pediatric Cardiomyopathy" University of Miami Cardiovascular Research Symposium; NHLBI Training Program in Cardiovascular Signaling (2008)
  • "The Future of Pediatric Cardiology - A Chair’s Perspective" Annual Scientific Session; American College of Cardiology; Pediatric and Congenital Heart Disease Career Session (2008)
  • "Cardiac Troponin Evaluation in Oncology" Bridging Preclinical and Clinical Application of Cardiac Troponins as a Tool to Evaluate Drug-Induced Cardiotoxicity Workshop; Health and Environmental Sciences Institute; Technical Committee on Development and Application of Biomarkers of Toxicity (2008)
  • "Cardiology - Hypertension in the Adolescent, Evaluation and Treatment Session C" Leadership Conference: Exploring Contemporary and Future Pediatrics; Masters of Pediatrics (2008)
  • "Frequent Mitochondrial DNA Mutations and Polymorphisms in Childhood Cancer Survivors Following Multi-Agent Chemotherapy" 3rd International Mitochondria Minisymposium: Mitochondria and Their Proteomics; National Cancer Institute (2008)
  • "The Impact of Epigenetics (gene-environment interaction) and Development on Pediatric Chronic Illnesses" MD-PhD Program Grand Rounds/Chalk Talk; University of Miami (2008)
  • "Cardiotoxicity in Cancer Patients" 15th Annual Scientific Retreat; University of Miami Sylvester Comprehensive Cancer Center (2007)
  • "How Should Cancer Patients with Cardiac Dysfunction be Followed and Treated?" Scientific Sessions; American Heart Association; Cancer Therapeutics and Cardiotoxicity Special Session (2007)
  • "Doxorubicin Cardiomyopathy: Mechanisms and Therapeutic Targets" 39th Annual Meeting; German Society of Pediatric Cardiology (2007)
  • "Hypertrophic Cardiomyopathy" 15th Anniversary Congress: The Future of Pediatric Cardiology; Belgian National Foundation for Research in Pediatric Cardiology (2007)
  • "New Insights from the U.S. Pediatric Cardiomyopathy Registry" 39th Annual Meeting; German Society of Pediatric Cardiology; Cardiomyopathies and Myocarditis Session (2007)
  • "Preventing Cardiotoxicity in Children" 10th Annual Conference; BioFlorida, Inc.; Cardiovascular and Vascular Diseases Session (2007)
  • "State of the Art Presentation: Cardiotoxicity of Non-Cardiac Drugs - Post Therapeutic Cardiomyopathy" 15th Anniversary Congress: The Future of Pediatric Cardiology; Belgian National Foundation for Research in Pediatric Cardiology; Cardiovascular Effects of ‘Non-Cardiac’ Diseases Session (2007)
  • "Cardiotoxicity in Childhood Cancer" ALL Investigators' Symposium; National Cancer Institute/Dana Farber Cancer Institute (2007)
  • "Radiotherapy and Cardiovascular Outcomes" 13th International Congress of Radiation Research; International Association for Radiation Research; Cardiovascular Late Effects of Radiation Sumposium (2007)
  • "Cardiovascular Effects of ART in Children" State-of-the-Science Conference: Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living with HIV/AIDS; American Heart Association/American Academy of HIV Medicine CVD/HIV Advisory Working Group (2007)
  • "Long-Term Follow-Up and Management of Children Who Have Received Cardiotoxic Treatment" 20th Anniversary Symposium on Supportive Care in Cancer; Multinational Association of Supportive Care in Cancer; Prevention and Management of Cardiotoxicity with Novel Cancer Therapies Parallel Session (2007)
  • "Prevention of Cardiotoxicity of Anticancer Agents" 9th Joint Meeting; Federation of European Cancer Societies/American Society of Clinical Oncology/American Association of Cancer Research; Methods in Clinical Cancer Research Workshop (2007)
  • "Promising Clinical Indications for NT-proBNP: Assessment of Cardiotoxicity" 5th proCardio Symposium; Roche Corporation (2007)
  • "Cardiovascular Disease in Pediatric Renal Failure" International Symposium on Pediatric Nephrology (2007)
  • "Late Cardiovascular Abnormalities in Long-Term Survivors of Childhood Cancer" Pediatric Grand Rounds; New York University School of Medicine-Bellevue Hospital Center (2007)
  • "Late Effects of Cancer and Its Therapy in Long-Term Survivors of Childhood Cancer" 4th Annual BeCause We Care; Children’s Cause for Cancer Advocacy (2007)
  • "New Cardiac Biomarkers of Cancer Therapy Related Cardiotoxicity" Investigator Meeting on Late Effects; National Cancer Institute (2007)
  • "Preventive Cardiology and Nutrition" Leadership Conference: Exploring Contemporary and Future Pediatrics; Masters of Pediatrics; Pediatric Nutrition: The Good, The Bad and The Ugly Symposium (2007)
  • "The Pediatrician’s Approach to the Child with Complex Congenital Cardiovascular Disease: A Multidisciplinary Team" Leadership Conference: Exploring Contemporary and Future Pediatrics; Masters of Pediatrics (2007)
  • "Cardiovascular Late Effects of Therapy for Childhood Cancer" Biobehavioral and Cancer Control Symposium; University of Miami Sylvester Comprehensive Cancer Center (2007)
  • "Consensus Recommendations for Future Areas of Epidemiologic and Outcomes Research in Pediatric Cardiomyopathy" Idiopathic and Primary Cardiomyopathy in Children: Research Directions and Strategies Conference; Children's Cardiomyopathy Foundation/University of Miami Miller School of Medicine; 1st Pediatric Cardiomyopathy Scientific Workshop (2007)
  • "Results from the NHLBI Pediatric Cardiomyopathy Registry" Idiopathic and Primary Cardiomyopathy in Children: Research Directions and Strategies Conference; Children’s Cardiomyopathy Foundation/University of Miami Miller School of Medicine; 1st Pediatric Cardiomyopathy Scientific Workshop (2007)
  • "International Collaborative Child Health Research" Basel Life Sciences Mission to Florida: A Partnership for the Future; State of Florida’s Enterprise Florida Organization/University of Miami Miller School of Medicine (2006)
  • "Cardioprotection During Pediatric Cancer Treatment" International Review Symposium: Cancer Therapy Improvement by Toxicity Reduction and Cardioprotection; Royal Society of Medicine (2006)
  • "Cardiovascular Late Effects in Long-Term Survivors of Childhood Cancer" 11th World Congress on Advances in Oncology and 9th International Symposium on Molecular Medicine (2006)
  • "Clinical Experience with Dexrazoxane" International Workshop on Anthracycline Cardiotoxicity: Molecular Mechanisms and Clinical Correlates; Menarini Foundation (2006)
  • "Improving Congenital Heart Surgical Outcome by Virtual Regionalization" Dedication of the National Children’s Heart Surgical Hospital; Ministry of Health of Ukraine/Children of Chernobyl Relief and Development Fund/Vohnyk Nadii Children’s Cardiovascular Surgery and Medical Center Program (2006)
  • "Latest Update on Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy During Childhood" Dedication of the National Children’s Heart Surgical Hospital; Ministry of Health of Ukraine/Children of Chernobyl Relief and Development Fund/Vohnyk Nadii Children’s Cardiovascular Surgery and Medical Center Program (2006)
  • "Pathophysiology of Anthracycline Chemotherapy and Radiation Associated Cardiomyopathies" CONQUER (Cardiology Oncology InterNational Quest to Educate and Research Heart Failure) Committee; University of Texas MD Anderson Cancer Center (2006)
  • "Risk: Benefit Ratio of Cardioprotectants" International Workshop on Anthracycline Cardiotoxicity: Molecular Mechanisms and Clinical Correlates; Menarini Foundation (2006)
  • "The Diagnosis, Treatment, and Outcome of Congestive Heart Failure from Fetus to Adolescent" Dedication of the National Children’s Heart Surgical Hospital; Ministry of Health of Ukraine/Children of Chernobyl Relief and Development Fund/Vohnyk Nadii Children’s Cardiovascular Surgery and Medical Center (2006)
  • "Cardiac Oncology Studies Update" Childhood ALL Consortium Investigator Meeting; National Cancer Institute/Dana Farber Cancer Institute (2006)
  • "Pediatric Bone Marrow Transplant Treatment Paradigms: The New Era and Beyond" CME Program; University of Miami Miller School of Medicine (2006)
  • "Potential Treatments of Radiation-Induced Cardiovascular Disease" Health Effects from Low-Level Radiation Symposium; International Atomic Energy Agency (2006)
  • "Late Cardiovascular Effects of Mediastinal Irradiation for Childhood Cancer" Twenty Years after Chernobyl: A Vision for the Future; Government of Ukraine/International Atomic Energy Agency (2006)
  • "The Cardiovascular Health of Children and Adults Following Chernobyl and Hiroshima" Rebirth, Renewal and Human Development: A Humanitarian Forum - Chernobyl 20th Anniversary; Government of Ukraine/Ukraine 3000/UNESCO/Children of Chornobyl Relief and Development Fund (2006)
  • "Ukrainian Pediatric Health Care" Presidential Conference: Partnerships for Health; Government of Ukraine (2006)
  • "Cancer Therapy Improvement by Toxicity Reduction and Cardioprotection" Symposium; Royal Society of Medicine (2006)
  • "Cardiac Late Effects of Non-Therapeutic Radiation Exposure" Radiation and Non-Cancer Diseases, Cardiovascular Disease International Conference; Radiation Effects Research Foundation (2006)
  • "Congestive Heart Failure in Fetuses, Neonates, Infants, Children, and Adolescents" Scientific Symposium; Masters of Pediatrics; Pediatric Cardiology Update 2006 Workshop (2006)
  • "Neonatal Origin of Childhood and Adult Hypertension" XXXIII Pediatric Nephrology Seminar (2006)
  • "Cardiovascular Status of HAART-Exposed Infants and Children" 9th International Conference on Environmental Mutagens and the 36th Annual Meeting; Environmental Mutagen Society; Transplacental Exposure to Nucleoside Analogs: Mitochondrial Damage and Fetal Health Symposium (2005)
  • "Heart Failure in AIDS: A Sleeping Giant?" International Congress on Heart Failure; European Society of Cardiology (2005)
  • "The Possible Role of Cytokines" International Congress on Heart Failure; European Society of Cardiology (2005)
  • "Anthracycline Cardiotoxicity: New Leads to an Old Mystery Symposium" XXV International Congress of Physiological Sciences; International Union of Physiological Sciences (2005)
  • "Baseline Predictors of Pediatric Cardiomyopathy Outcomes" Pediatric Heart Transplant Study Meeting; International Society of Heart and Lung Transplantation (2005)
  • "Cardiac Troponin T as an Early Marker for Cardiotoxicity" XXV International Congress of Physiological Sciences; International Union of Physiological Sciences (2005)
  • "Anthracycline Cardiotoxicity" Invited Presentation; Lovelace Respiratory Research Institute (2005)
  • "Cardiac Studies" ALL Investigators’ Meeting and Field Coordinators’ Meeting; National Cancer Institute/Dana Farber Cancer Institute (2005)
  • "Cardiac Studies in HIV" Scientific Oversight Committee; National Institutes of Health PHACS (2005)
  • "Cardiotoxic Effects of Cancer Therapy in Children" Annual Meeting of the Joint Cancer Conference of the Florida Universities; ; Pediatric and Adolescent Cancers Special Interest Panel Sessions (2005)
  • "Cardiotoxic Late Effects in Long-Term Survivors of Childhood Cancer" Alumni Symposium; Case Western Reserve University/Rainbow Babies and Children's Hospital (2005)
  • "Cardiovascular Issues in Pediatric Chronic Kidney Failure" 30th International Symposium on Pediatric Nephrology (2005)
  • "Cardiovascular Status of HAART-Exposed Infants and Children" Women and Infants’ Transmission Study Executive Committee Meeting; National Institutes of Health (2005)
  • "Cardiovascular Status of HAART-Exposed Infants and Children" Highly-Active Antiretroviral Therapy Grantees Meeting; National Heart, Lung and Blood Institute (2005)
  • "Congestive Heart Failure in Pediatrics" Pediatric Multi-Specialty Review Conference; Baptist Children's Hospital (2005)
  • "Fetal Origins of Adult Cardiovascular Disease" 32nd Annual International Symposium on Neonatology; University of Miami (2005)
  • "HAART-Associated Cardiovascular Toxicity" Clinical Research Forums in Pediatrics; University of Miami Miller School of Medicine (2005)
  • "Late Cardiotoxicity in Long-Term Survivors of Childhood Cancer" Meet the Professors Program; Masters of Pediatrics (2005)
  • "Late Cardiotoxicity in Survivors of Childhood Cancer" Grand Rounds; University of Miami Sylvester Comprehensive Cancer Center (2005)
  • "Pediatric Oncology - Active Issues" Stop Children’s Cancer Now! Foundation Meeting; Stop Children's Cancer (2005)
  • "The Pediatric Cardiomyopathy Registry" NIH Special Emphasis Panel Working Group on Cardiomyopathies of Rare Diseases; NHLBI Division of Heart and Vascular Diseases/NIH Office of Rare Diseases (2005)
  • "Advocacy in Action" Heart University/ICOS/Sofia’s Hope Webinar Series on Pediatric Cardio-Oncology
See all (327 more)

Service Activities:
  • Invited to be a Consultant, Rocket Pharma. Susan Manganaro, MD, MBA, Senior Medical Director, Global Medical Affairs, (smanganaro@rocketpharma.com). George Varghese, MD, Senior Medical Science Liaison-AAV (US, East Coast) (gvarghese@rocketpharma.com); Consultant (2024–present)
  • Children’s Cardiomyopathy Foundation Research Grant Application - “Biomarkers in Pediatric Cardiomyopathies: a PCMR Multicenter Study”; Investigator (2024–present)
  • NHLBI resubmission RO1 grant application (HL175998) as the communicating principal investigator (Lipshultz SE). This NHLBI grant application is titled “Multi-Omic Assessment in Pediatric Dilated Cardiomyopathy. On December 13, 2024, era-notified us that this grant application was assigned an Agency Tracking Number as electronic application number: AN#5087806 and has a Grants.gov Tracking #: GRANT14318305. Thus 308-page grant has a start date of 07/01/2025 and an ending date of 06/30/2030. The total federal funds requested are $9,707,216.00. This grant application has 31 project/performance sites. Dilated cardiomyopathy is the most diagnosed cardiomyopathy of childhood, where 70% experience heart failure and 60% of those fail medical management within two years, resulting in death or cardiac transplantation. This research aims to accurately predict patient outcomes through identification of specific proteins, microRNAs, biomarkers, and echocardiographic measurements with novel machine learning algorithms designed to best meet the needs of children with DCM. With accurate prediction, novel therapies to promote cardiac recovery can be quickly administered and, for those predicted to fail medical management, ventricular assist devices and heart transplantation can be started as soon as possible, thereby reducing morbidity and mortality, enhancing quality of life, and more appropriately allocating emotional support and financial resources. This grant application was given ID on December 20, 2024, as 1RO1HL175889-01A1 and was assigned to the Cardiovascular and Respiratory Diseases (CRD) panel for review on February 13, 2025.; Principal Investigator (2024–present)
  • ; Invited Plenary Keynote Speaker, Cuban 8th Cardio-Oncology Symposium (2024–2025)
  • Clinical Cancer Survivorship Research: Learning Collaboratives, Lessons Learned, and Active Research Findings (speaker and moderator), Fireside Chat: History of the Discovery and Development of Dexrazoxane (moderator), Dr. Jacob Adams Lecture at the Second International Conference on Cardio-Oncology in Children.; Founder, Co-Leader, and Speaker (2024)
  • "Management and Treatment Strategies for Cardiomyopathies in Children” - Cardiogenetics Scientific Summit; Keynote Plenary Speaker (2024)
  • Heart University/ICOS/Sofia’s Hope Webinar Series on Pediatric Cardio-Oncology. “Advocacy in Action” Pediatric Cardio-Oncology. Speakers: 1. Steve Wosahla, CEO, Children’s Cancer Cause and Sue Emmer, I Street Advocates.; Moderator (2024)
  • Pediatric Cardiomyopathy Registry Scientific Retreat; Organizer (2024)
  • Children’s Cardiomyopathy Foundation Medical Advisory Board Meeting; Organizer (2024)
  • Second International Conference on Pediatric Cardio-Oncology; Principal Investigator, Organizer, and Chair, Steering Committee (2024)
  • Co-investigator (10% FTE, subaward PI)-NIH RO1 on “Elucidating the Genetic Susceptibility to Anthracycline Cardiotoxicity.” 07/01/25-06/30/30. Towbin JA (contact PI), Purevjav E, Lu L (MPIs), University of Tennessee Health Sciences Center, Memphis, TN; Co-investigator (2024–present)
  • Children’s Hospital Los Angeles and Visiting Professor, Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA; Invited Pediatric Grand Rounds Speaker (2024)
  • Children’s Cardiomyopathy Foundation Webinar: Evaluating Children with Hypertrophic Cardiomyopathy: Importance of Cardiac MRI; Moderator (2024)
  • Mayo Clinic. Rochester, MN; Pediatric Grand Rounds Speaker and Visiting Professor (2024)
  • U240070-Academic Scholar – Clinical or Research Assistant, Associate or Full Professor, Department of Pediatrics, Division of Neonatology, University at Buffalo. (Lauren Merletti, September 11, 2024).; Search Committee Member - UB (2024)
  • ; Editor-in-Chief, Progress in Pediatric Cardiology. Elsevier (2024–present)
  • Chair, External Advisory Committee of an NIH Centers of Biomedical Research Excellence (COBRE-Diabetes) grant from the National Institute of General Medical Sciences renewal on Diabetes and Metabolic Diseases. University of Hawaii John A. Burns School of Medicine, Honolulu, HI. Competing renewal submitted May 26, 2023, for 5 years. Principal Investigator-Mariana Gershenson, PhD. Received a score of 22 and is scheduled to start funding for 5 years in August 2024. NOGA received April 2024. Major Goals: “This program grant is to train junior faculty and develop infrastructure at the University of Hawaii at Manoa in diabetes and insulin resistance.” The Advisory Committee that Dr. Lipshultz leads provides programmatic oversight and mentoring guidance. The AC meets twice a year. The AC’s responsibilities include providing general oversight, suggestions for mentoring, consideration of providing evaluation metrics, and scientific advice for the COBRE and for the individual projects. The goal of the AC is to evaluate whether the goals of the Center remain well aligned with the institution’s strategic priorities, evaluate the scientific progress of the supported RPLs, PPLs, and Metabolic and Analytic Core, evaluation RPL, progress toward acquiring independent research funding, and reviewing/approving proposals for replacement research projects when such a need arises. Project Number: 5 P20 GM113134-06. Project Start and End Date: 08/2024-07/2029. Total Award Amount (including indirect costs): $11,737,500. drc.jabsom.hawaii.edu. https://drc.jabsom.hawaii.edu/about/purpose-of-cobre.html.; Chair, External Advisory Committee - COBRE-Diabetes Grant (2024–present)
  • Advances in Pediatric Cardiomyopathy-6th International Conference Highlights. Speaker on Pediatric Dilated Cardiomyopathy Update.; Featured speaker and moderator - Children’s Cardiomyopathy Foundation Webinar (2024)
  • NIH Pediatric HIV-AIDS Cohort (PHACS) study annual investigator meeting; Invited Cardiopulmonary Working Group Session Leader (2024)
  • BioMed Central ISSN: 2057-3804. (Alison Mercer, Associate Publisher for the Clinical Medicine Portfolio: Science+Business Media-4/14, Norbert Kurzel, Editorial Manager for Cardio-Oncology, Implementation Manager of the Springer Journal’s Editorial Office; Editor-in-Chief, Cardio-Oncology (2024–present)
  • Member of the External Advisory Board of the St. Jude Lifetime Cohort (SJLIFE) Study. Keri Ness, PhD and Melissa Hudson, MD-PIs. Invited June 2024 for submission before the July 29, 2024, deadline for funding from 2025-2030. Current Award Number: NCI U01 CA195547 - PAR-14-160 Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts; Sponsor: NCI. Competitive renewal application for PAR-22-162, “Research Opportunities in Established Cancer Epidemiology Cohort Studies” (NIH).; Invited to continue to be Member of the External Advisory Board (2024–present)
  • Children’s Cardiomyopathy Foundation Research Grant Proposal for support to the Pediatric Cardiomyopathy Registry and Children’s Cardiomyopathy Foundation Medical Advisors Meeting. $25,000.; Principal Investigator - Children’s Cardiomyopathy Foundation Research Grant Proposal (2024–present)
  • Clinical Practice Guideline of the National Cancer Institute Children’s Oncology Group Supportive Care Committee; Stakeholder Reviewer (2024–present)
  • HESI THRIVE grant program. LOIs reviewed and 22 finalists selected. May 2024. 19 final applications reviewed August 2024. On September 17, 2024, funded 4 proposals to nurture fresh talent, new ideas, and spread the seeds of innovation.; Scientific Review Committee Member (2024)
  • 6th International Conference on Cardiomyopathy in Children; Founder, organizer, co-chair steering committee, co-chair planning committee (2024)
  • “Management of Asymptomatic Dilated Cardiomyopathy.” In “Dilated Cardiomyopathy in Children” Session. Sixth International Conference on Cardiomyopathy in Children. A virtual conference.; Invited Plenary Speaker (2024)
  • Sixth International Conference on Pediatric Cardiomyopathy; Principal Investigator, Organizer, Chair, Planning Committee, and Chair, Steering Committee (2024)
  • Health and Environmental Sciences Institute (HESI) Thrive Program for innovating translational research to improve quality of life after cancer. Reviewer of final 18 proposals for consideration for funding. July 2023. Syril Petit, DrPH, MEM, Executive Director, and Shermaine Mitchell-Ryan. This was also repeated for the 2024 cycle where letters of intent were submitted in April 2024, invited full applications in August 2024. Of more than 100 letters of intent, 19 complete applications were submitted and 4 were funded in September 2024.; Founding and Continuing Member of the Scientific Advisory Committee (2024)
  • Executive Director, Children’s Cardiomyopathy Foundation & SUNY Research Foundation, Pediatrics (Kathy Swenson); Search Committee Member, Chair - UB (2024)
  • Invited to be the 2024 Robert T. Wong, M.D. Keynote Lecturer on our research for the 2024 John A Burns School of Medicine Biomedical Sciences Symposium; 2024 Robert T. Wong, M.D. Keynote Lecturer (2024)
  • Management and Treatment Strategies for Cardiomyopathies in Children: Are Children Small Adults?” Hawai’i Pacific Health: Straub Medical Center, Honolulu, Hawaii.; Invited Grand Rounds Speaker (2024)
  • NCI-Dana-Farber Childhood Cancer Investigator Meeting. "Cardiac Late Effects: Update”. Harvard Dana-Farber Cancer Institute, Boston, MA; Invited Plenary Speaker (2024)
  • Chief Medical Officer, Children’s Cardiomyopathy Foundation, Tenafly, NJ. Appointed April 2024. Dr. Lipshultz was a founder in 2001 and has remained continuously active as Chair, Medical Advisory Board since. This not-for-profit organization has raised nearly $19 million for research to improve outcomes for children with cardiomyopathy.; Chief Medical Officer, Children’s Cardiomyopathy Foundation (2024–present)
  • Senior Project Coordinator, Children’s Cardiomyopathy Foundation & SUNY Research Foundation, Pediatrics (Leah Mumm); Search committee member, Chair - UB (2024)
  • “Pediatric Cardiomyopathy Care Considerations.” Children’s Cardiomyopathy Foundation - Experts on Pediatric Cardiomyopathy Educational Webinar Series; Invited Moderator and Speaker (2024)
  • Experts on Pediatric Cardiomyopathy Educational Webinar Series. Children’s Cardiomyopathy Foundation. “Management and Treatment Guidelines for Cardiomyopathies in Children.”; Invited Webinar Speaker (2024)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences Medical Student Annual Research Forum-provided feedback and guidance to 5 medical students.; Judge (2024)
  • NIH 1R01HL176579-01. Towbin JA-PI (Enkhe Pruevjav-investigator). Cardiac muscle LIM protein (MLP)-related cardiomyopathies; Consultant (2024–present)
  • 10th Anniversary of the Senior Scholar Program in Pediatric Cardiomyopathy. Funded by investigator-initiated research grants from the Children’s Cardiomyopathy Foundation and the Kyle John Foundation. The purpose is to provide funding to a senior research scholar to conduct clinical research in a mentored research experience focused on pediatric cardiomyopathies as part of the Pediatric Cardiomyopathy Registry. The first senior scholar was Dr. Paul Barach who is now a world leader in pediatric cardiac quality, safety, and outcomes with many NIH grants and publications. The second senior scholar was Dr. Neha Bansal who became the Chief of Pediatric Heart Failure and Transplant Cardiology at Montefiore Medical Center and is now a senior cardiologist in this specialty at Mount Sinai Medical Center in New York where she is an accomplished academic investigator and author. Another Senior Scholar was Dr. Sonya Kirmani who is now the Director of the Pediatric Heart Failure, Ventricular Assist Device and Transplant program in Pediatric Cardiology at the University of Wisconsin School of Medicine and Public Health. Yet another Senior Scholar has been Dr. Justin Godown who became the Associate Director of the Pediatric Heart Transplantation program, Medical Director of the Pediatric Cardiomyopathy Program, and Medical Director of Pediatric Cardio-Oncology Program at the Monroe Carell Jr. Children’s Hospital at Vanderbilt University. Dr. Godown is an accomplished academic investigator and author in this area and is now in a senior pediatric heart failure clinical trials leadership position in the pharmaceutical industry. The track record of this program is stellar and has increased the number of academic clinical and translational leaders in this field. Dr. Lipshultz started this program and has continuously mentored and lead this program.; Developer, Leader & Mentor for the Senior Scholar Program in Pediatric Cardiomyopathy (2024)
  • Advised and reviewed Daniel Maywalt's peer reviewed, first authored original research paper in May 2024 that was selected for an award. Mr. Maywalt is an author on 3 review articles/book chapters. Mr. Maywalt presented the results of his University at Buffalo Medical Student summer research with Dr. Lipshultz in February 2024 at the annual research symposium for medical students.; Advisor/Reviewer (2024–present)
  • Children’s Cardiomyopathy Foundation Webinar Series and Library; Medical Director (2024–present)
  • Sofia’s Hope Webinar Series and Library; Medical Director (2024–present)
  • Children’s Cancer and Leukaemia Group (CCLG) and The Little Princess Trust (LPT) Grant Program to support research into childhood cancers; Reveiwer (2024–present)
  • Journal of Human Hypertension; Reviewer (2024–present)
  • Nutrition; Reviewer (2024–present)
  • Nature Reviews Cardiology; Reviewer (2024–present)
  • Journal of Clinical Medicine; Reviewer (2024–present)
  • JNCCN-Journal of the National Comprehensive Cancer Network; Reviewer (2024–present)
  • UK Research and Innovation Funding Service-MRC Pre doctoral clinical research training fellowship (CTRF); Reviewer (2024–present)
  • The Lancet Rheumatology; Reviewer (2024–present)
  • UBMD Pediatrics: Board of Directors; President (2019–present)
  • American Journal of Hematology; Reviewer (2019–present)
  • European Science Foundation: Science Connect; Reviewer (2019–present)
  • Friends of Rosie Children's Cancer Research Fund: Pump-Priming Research Grant; Reviewer (2019–present)
  • Journal of Pediatric Cardiology; Reviewer (2019–present)
  • Journal of the American College of Cardiology - Cardio-Oncology; Reviewer (2019–present)
  • National Council on Radiation Protection and Measurements: SC 1-26 Scientific Committee Review; Reviewer (2019–present)
  • Open Forum Infectious Diseases; Reviewer (2019–present)
  • Plant Science Today; Reviewer (2019–present)
  • The Open AIDS Journal; Reviewer (2019–present)
  • Journal of Clinical Therapeutics and Diagnosis; Editorial Board Member (2018–present)
  • Clinics in Pediatrics; Editorial Board Member (2018–present)
  • Annals of Medicine and Medical Research; Editorial Board Member (2018–present)
  • Archives of Diabetes & Obesity; Editorial Board Member (2018–present)
  • Translational Pediatrics; Associate Editor (2018–present)
  • Journal of Child Science; Editorial Board Member (2018–present)
  • Gene Science and Engineering; Editorial Board Member (2018–present)
  • Imaging and Radiation Research; Editorial Board Member (2018–present)
  • Springer Clinical Medicine Book Proposal; Reviewer (2018–present)
  • Pulmonary Disease Case Reports; Editorial Board Member (2017–present)
  • Research and Reports of Medicine; Editorial Board Member (2017–present)
  • Open Epidemiology Journal; Editorial Board Member (2017–present)
  • Journal of Diabetic Complications & Research; Editorial Board Member (2017–present)
  • JENPUB Cardiology and Cardiovascular Diseases; Editorial Board Member (2017–present)
  • Journal of Hypertension and Heartcare; Editorial Board Member (2017–present)
  • Journal of HIV/AIDS Research and Therapy; Editorial Board Member (2017–present)
  • Journal of Neonatal Care; Editorial Board Member (2017–present)
  • Journal of Neonatal Studies; Editorial Board Member (2017–present)
  • Journal of AIDS and Immune System; Editorial Board Member (2017–present)
  • Journal of Endocrinology & Research Studies; Editorial Board Member (2017–present)
  • Open Enzyme Inhibition Journal; Editorial Board Member (2017–present)
  • International Journal of Research in Pharmacology Studies; Editorial Board Member (2017–present)
  • Current Chemical Genomics and Translational Medicine; Editorial Board Member (2017–present)
  • Canadian Journal of Applied Sciences; Editorial Board Member (2017–present)
  • Pediatric Dimensions; Editor-In-Chief (2017–present)
  • Proclins Cardiology; Editorial Board Member (2017–present)
  • Scientific Journal of Cardiovascular Disorders; Editorial Board Member (2017–present)
  • Journal of Advanced Pediatrics and Child Health; Editorial Board Member (2017–present)
  • Journal of Immunology and Vaccination; Editorial Board Member (2017–present)
  • Cardiovascular & Hematological Agents in Medicinal Chemistry; Editorial Board Member (2017–present)
  • Annals of Cardiovascular Surgery; Editorial Board Member (2017–present)
  • American Journal of Epidemiology & Public Health; Editorial Board Member (2017–present)
  • Advances in Cardiovascular and Cerebrovascular Diseases; Editorial Board Member (2017–present)
  • Current Obesity Research & Therapy; Editorial Board Member (2017–present)
  • Current Opinion in Gynecology and Obstetrics; Editorial Board Member (2017–present)
  • Clinical Research in Pediatrics; Editorial Board Member (2017–present)
  • International Journal of Forensic Medicine and Toxicological Science; Editorial Board Member (2017–present)
  • HIV and AIDS Research Journal; Editorial Board Member (2017–present)
  • GSL Journal of Pediatrics; Editorial Board Member (2017–present)
  • International Journal of Obstetrics and Gynaecology; Editorial Board Member (2017–present)
  • American Journal of Family Medicine; Editorial Board Member (2017–present)
  • Annals of Blood Cancer; Editorial Board Member (2017–present)
  • Journal of Genetics and Molecular Biology; Editorial Board Member (2017–present)
  • Journal of Cardiology & Diagnostics Research Founder and Co-Editor-in-Chief (2017–present)
  • Open Cardiovascular Medicine Journal; Advisory Board (2017–present)
  • Infectious Disorders – Drug Targets; Advisory Board (2017–present)
  • Clinical Cancer Drugs; Advisory Board (2017–present)
  • Remedy Publications e-Books Initiative: Cardiology & Cardiovascular Disease; Editor (2017–present)
  • SM Blood Disorders and Transfusion; Editorial Board Member (2017–present)
  • Journal of Family Medicine Forecast; Editorial Board Member (2017–present)
  • Journal of Cardiology Forecast; Editorial Board Member (2017–present)
  • Journal of Microbiology and Biotechnology Reports; Editorial Board Member (2017–present)
  • Family Medicine and Public Health Care Reports; Editorial Board Member (2017–present)
  • Drug Delivery Letters; Editorial Board Member (2017–present)
  • Annals of Atherosclerosis Research; Editorial Board Member (2017–present)
  • Annals of Medical Case Reports: Pediatric Case Reports; Editorial Board Member (2017–present)
  • Advances in Clinical Toxicology; Editorial Board Member (2017–present)
  • Women’s Health Research; Editorial Board Member (2017–present)
  • Journal of Nutrition and Food Science Forecast; Editorial Board Member (2017–present)
  • Journal of Physical Medicine and Rehabilitation Medicine Forecast; Editorial Board Member (2017–present)
  • Open Biomarkers Journal; Editorial Board Member (2017–present)
  • Pediatric Research and Neonatal Care; Editorial Board Member (2017–present)
  • SM Genetic Syndromes & Gene Therapy; Editorial Board Member (2017–present)
  • SM Pediatrics & Neonatal Biology; Editorial Board Member (2017–present)
  • EMS Pulmonology; Editorial Board Member (2017–present)
  • Integrative Clinical Cardiology; Editorial Board Member (2017–present)
  • International Journal of Cardiology and Cardiovascular Medicine; Editorial Board Member (2017–present)
  • GSL Journal of Genetics Syndromes & Therapy; Editorial Board Member (2017–present)
  • GSL Journal of Pediatric Surgery; Editorial Board Member (2017–present)
  • Women's Health Science Journal; Editorial Board Member (2017–present)
  • Nationwide Children’s Hospital/Ohio State University: NHLBI Weinstein Cardiovascular Development and Regeneration Meeting; Chair (2017)
  • Journal of Integrative Pediatric Healthcare: Open Access; Editorial Board Member (2017–present)
  • Journal of Gynecology and Infertility; Editorial Board Member (2017–present)
  • Journal of Hematology and Clinical Research; Editorial Board Member (2017–present)
  • Journal of Pregnancy and Reproduction; Editorial Board Member (2017–present)
  • Journal of Stem Cell Therapy and Transplantation; Editorial Board Member (2017–present)
  • EMS Gynecology Journals; Editorial Board Member (2017–present)
  • Annals of Cancer Research and Therapeutics; Editorial Board Member (2017–present)
  • Annals of Trauma and Acute Care; Editorial Board Member (2017–present)
  • Austin Leukemia; Editorial Board Member (2017–present)
  • Cardiovascular & Hematological Disorders-Drug Targets; Editorial Board Member (2017–present)
  • Annals of Pediatric Research; Editorial Board Member (2017–present)
  • International Journal of Obstetrics and Gynecology; Editorial Board Member (2017–present)
  • EC Pulmonary and Respiratory Medicine Journal; Editorial Board Member (2017–present)
  • The Scientific Pages of Cardiothoracic Surgery; Editorial Board Member (2017–present)
  • The Scientific Pages of Gene and Genome Research; Editorial Board Member (2017–present)
  • Open Access Journal of Cardiology; Editorial Board Member (2017–present)
  • Open Access Journal of Case Reports; Editorial Board Member (2017–present)
  • Journal of Pediatric Diseases; Editorial Board Member (2017–present)
  • International e-Journal of Gynecology & Obstetrics; Editorial Board Member (2017–present)
  • Annals of Nutrition and Metabolism; Reviewer (2017–present)
  • The Physician and Sportsmedicine; Reviewer (2017–present)
  • EC Pediatrics; Editorial Board Member (2016–present)
  • EC Cardiology; Editorial Board Member (2016–present)
  • Annals of Infectious Disease and Epidemiology; Editorial Board Member (2016–present)
  • The Scientific Pages of Pulmonology; Editorial Board Member (2016–present)
  • Journal of Cardiovascular Disorders; Editorial Board Member (2016–present)
  • Journal of Gynecology and Women’s Health; Editor (2016–present)
  • CRESSCO International Journal of Pediatrics; Editorial Board Member (2016–present)
  • Gynecology and Women’s Health Research; Editorial Board Member (2016–present)
  • Austin Cardiology; Editorial Board Member (2016–present)
  • Journal of Gynecology & Obstetrics; Editorial Board Member (2016–present)
  • International Journal of Pregnancy and Childbirth; Editorial Board Member (2016–present)
  • The Scientific Pages of Pediatrics; Editorial Board Member (2016–present)
  • The Scientific Pages of Gynecology and Obstetrics; Editorial Board Member (2016–present)
  • SM Journal of Cardiovascular Disorders; Editorial Board Member (2016–present)
  • SM Journal of Pediatrics; Editorial Board Member (2016–present)
  • Austin Transplantation Sciences; Editorial Board Member (2016–present)
  • Annals of Cardiology and Cardiovascular Diseases; Editorial Board Member (2016–present)
  • Research Journal of Clinical Pediatrics; Editorial Board Member (2016–present)
  • The Scientific Pages of Heart; Editorial Board Member (2016–present)
  • The Scientific Pages of Emergency Medicine; Editorial Board Member (2016–present)
  • SciTz Pediatrics & Therapeutics; Editorial Board Member (2016–present)
  • Patient Related Outcome Measures; Editorial Board Member (2016–present)
  • Adolescent Health, Medicine and Therapeutics; Editor-In-Chief (2016–present)
  • Clinics in Oncology; Editorial Board Member (2016–present)
  • American Association of University Professors-American Federation of Teachers: Wayne State University Chapter Union Member (2016–2018)
  • Children’s Hospital of Michigan: Schwartz Rounds Committee Physician Leader (2016–2017)
  • Children’s Hospital of Michigan: Labor Productivity and Overtime Committee; Committee Member (2016–2017)
  • Children’s Hospital of Michigan: Ambulatory Leadership Meeting; Member (2016–2017)
  • Insights in Pediatric Cardiology; Editorial Board Member (2016–present)
  • BMJ Open; Reviewer (2016–present)
  • AIDS Care; Reviewer (2016–present)
  • American Heart Association: Scientific Sessions Committee; Reviewer (2016–present)
  • Journal of Pediatrics and Clinical Nutrition; Reviewer (2016–present)
  • Heart Institutes at Rady Children’s Hospital/UC San Diego/Children’s Hospital of Orange County: Innovations in Pediatric Heart Failure Symposium Co-Moderator (2015)
  • Journal of Antivirals, Antiretrovirals Research and Therapy; Editorial Board Member (2015–present)
  • Trends in HIV/AIDS; Editorial Board Member (2015–present)
  • ARC Journal of Surgery; Editorial Board Member (2015–present)
  • Insights in Cancer Research; Editorial Board Member (2015–present)
  • University of Michigan/C.S. Mott Children’s Hospital: Joint Conference on Advances in Pediatric Cardiovascular Disease Management Invited Plenary Session Moderator (2015)
  • Journal of Pediatrics and Child Nutrition; Editor-In-Chief (2015–present)
  • Progress in Pediatric Cardiology; Editor-In-Chief (2015–2019)
  • Cardio-Oncology; Editor-In-Chief (2015–2019)
  • Detroit Medical Center: Charter AS-02 DMC-M05 Surfactant Study Data and Safety Monitoring Board; Chair (2015–2018)
  • Children‘s Hospital of Michigan Premier Network: Executive Committee and Operating Committee; Committee Member (2015–2018)
  • American Association for the Advancement of Science: Research Competitiveness Program - Literature Review of the Safety of Caffeine; Panel Member (2015–2016)
  • Detroit Medical Center: Gateway Advisory Board; Board Member (2015–present)
  • Children’s Hospital of Michigan: Medical Administrative Review Committee; Committee Member (2015–present)
  • Children’s Hospital of Michigan: Service Demand Committee; Committee Member (2015–present)
  • ARC Journal of Paediatrics; Editorial Board Member (2015–present)
  • Cardiovascular Disease in the Young; Editorial Board Member (2015–present)
  • International Journal of Pediatric Research; Editorial Board Member (2015–present)
  • Children’s Hospital of Michigan: Tier 4 Meeting; Member (2015–present)
  • Children’s Hospital of Michigan: Executive Leadership Team Meeting; Member (2015–present)
  • Children’s Hospital of Michigan: Clinically Integrated Network Infrastructure Work Group; Member (2015–present)
  • Children’s Hospital of Michigan: Clinically Integrated Network Leadership Task Force; Member (2015–present)
  • Children’s Hospital of Michigan: Regulatory Readiness Rounds; Member (2015–present)
  • Detroit Medical Center: Strategy and Performance Group; Member (2015–present)
  • International Journal of Environmental Research and Public Health; Reviewer (2015–present)
  • European Journal of Nutrition; Reviewer (2015–present)
  • Cancer Medicine; Reviewer (2015–present)
  • JAMA Oncology; Reviewer (2015–present)
  • Clinical Research in HIV/AIDS; Editorial Board Member (2014–present)
  • International Journal of Pediatrics and Child Health Co-Editor-in-Chief (2014–present)
  • University Campus Bio-Medico of Rome/Fondazione Internationale Menarini: International Colloquium on Cardio-Oncology; Co-Chair (2014)
  • Journal of Trauma and Care; Editorial Board Member (2014–present)
  • Children‘s Hospital of Michigan: Physician Leadership Committee; Committee Member (2014–2018)
  • Wayne State University School of Medicine: Fund for Medical Research and Education; Board of Trustees Member (2014–2016)
  • Future Cardiology; Guest Editor (2014–2015)
  • Children’s Hospital of Michigan: McKinsey Engagement Steering Committee; Committee Member (2014)
  • C.S. Mott Center for Human Growth and Development: Internal Advisory Committee; Committee Member (2014–present)
  • Michigan State University Institute for Health Policy: CHARM Working Group; Member (2014–present)
  • Minerva Pediatrica; Reviewer (2014–present)
  • Journal of Caffeine Research; Reviewer (2014–present)
  • Pharmacogenomics; Reviewer (2014–present)
  • Nutrients; Reviewer (2014–present)
  • Heart; Reviewer (2014–present)
  • Clinical Medicine Insights: Cardiology; Reviewer (2014–present)
  • Cancer Research UK; Reviewer (2014–present)
  • Cardiovascular Research; Reviewer (2014–present)
  • Children; Reviewer (2014–present)
  • Austin Journal of HIV/AIDS Research; Editorial Board Member (2013–present)
  • Open Journal of Pediatrics; Editorial Board Member (2013–present)
  • Wayne State University School of Medicine: Combined Chairs Group; Member (2013–2016)
  • Wayne State University: Search Committee for the Vice President for Research; Chair (2013–2014)
  • Children’s Hospital of Michigan: Service Chiefs, Center Directors and Joint Operating Committee Meeting Leader (2013–present)
  • Children’s Hospital of Michigan: Medical Provider Meeting Leader (2013–present)
  • Barbara Ann Karmanos Cancer Institute: Population Studies and Disparities Research Program Scientific Member (2013–present)
  • University Pediatricians; Board of Directors (2013–present)
  • Children‘s Hospital of Michigan; Board of Trustees Member (2013–present)
  • Children‘s Hospital of Michigan Foundation; Board of Trustees Member (2013–present)
  • Children’s Hospital of Michigan Foundation: Grants and Compliance Committee; Committee Member (2013–present)
  • Children’s Hospital of Michigan: Medical Staff Operations Committee; Committee Member (2013–present)
  • Children’s Hospital of Michigan: Peer Review Committee; Committee Member (2013–present)
  • Children’s Hospital of Michigan: Graduate Medical Education Committee; Committee Member (2013–present)
  • Children’s Hospital of Michigan: Board of Trustees Executive Committee; Committee Member (2013–present)
  • Children’s Hospital of Michigan: Board of Trustees Quality Assurance Committee; Committee Member (2013–present)
  • University Pediatricians: Compensation Committee; Committee Member (2013–present)
  • Detroit Medical Center: Medical Executive Committee; Committee Member (2013–present)
  • Wayne State University School of Medicine: Pediatric Promotion and Tenure Committee; Committee Member (2013–present)
  • Wayne State University School of Medicine: Cancer Biology Graduate Program; Member (2013–present)
  • Detroit Medical Center: Quality and Safety Leadership Team; Member (2013–present)
  • Detroit Medical Center: Executive Management Team; Member (2013–present)
  • Children’s Hospital of Michigan: Management Forum; Member (2013–present)
  • Children’s Hospital of Michigan: Physician Leadership Council; Member (2013–present)
  • Children’s Hospital of Michigan: Transplant Quality Council; Member (2013–present)
  • Children’s Hospital of Michigan: 30/60/90 Market Growth Meeting; Member (2013–present)
  • Children’s Hospital of Michigan: EBIDTA & CHET Group; Member (2013–present)
  • Children’s Hospital of Michigan: Executive Leadership Group; Member (2013–present)
  • Children’s Hospital of Michigan: Executive Leadership Staff and Patient Rounds Group; Member (2013–present)
  • Annals of Clinical & Experimental Hypertension; Editorial Board Member (2013–present)
  • Clinical Cancer Drugs; Editorial Board Member (2013–present)
  • Journal of Cardiology and Therapy; Editorial Board Member (2013–present)
  • Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES). NHLBI study.; Study Chair/Principal Investigator (2013–present)
  • World Journal of Cardiology; Editorial Board Member (2013–2017)
  • NIH: Clinical and Translational Science Awards Program; Member (2013–2014)
  • Edorium Journal of Pediatrics; Editor (2013)
  • NIH: HIV/AIDS Clinical Trials Network Registered Investigator (2013–present)
  • Valsartan for Attenuating Disease Evolution in Early Sarcomeric HCM: Multicenter Prospective Intervention Study Protocol Executive Committee; Committee Member (2013–present)
  • HESI: Cardiac Alternative Animal Modeling Subteam; Member (2013–present)
  • HIV/AIDS - Research and Palliative Care; Reviewer (2013–present)
  • Expert Opinion on Drug Discovery; Reviewer (2013–present)
  • Circulation: Cardiovascular Imaging; Reviewer (2013–present)
  • Cancer Epidemiology, Biomarkers & Prevention; Reviewer (2013–present)
  • The Lancet Oncology; Reviewer (2013–present)
  • PLOS One; Reviewer (2013–present)
  • Journal of the American College of Cardiology - Heart Failure; Reviewer (2013–present)
  • Frontiers in Pediatrics; Associate Editor (2012–present)
  • Biomarker Research; Editorial Board Member (2012–present)
  • Open Journal of Safety Science and Technology; Editorial Board Member (2012–present)
  • World Research Journal of Cardiology; Editorial Board Member (2012–present)
  • Journal of the International AIDS Society; Reviewer (2012–present)
  • World Journal of Hematology; Editor-In-Chief (2011–2015)
  • Registered Member, National Cancer Institute-sponsored Phase III Cancer Treatment Trials as a registered member of the Cancer Trials Support Unit (CTSU). NCI Cooperative Group Treatment Affiliation: COG. NCI Cancer Therapy Evaluation Program (CTEP) Investigator.; Registered Member & Investigator (2011–present)
  • Chris Evert Children’s Hospital: Leadership Advisory Board; Board Member (2011–2012)
  • UHealth: Committee on Conflicts of Interest; Committee Member (2011–2012)
  • University of Miami Miller School of Medicine: Comparative Effectiveness Research Group; Member (2011–2012)
  • Children‘s Oncology Group: Protocol ALTE11C2 Committee; Committee Member (2011–present)
  • Pediatrics & Therapeutics: Current Research – Open Access; Editorial Board Member (2011–present)
  • Open Journal of Cardiology; Editorial Board Member (2011–present)
  • Pediatric Hematology and Oncology; Reviewer (2011–present)
  • Swiss Medical Weekly; Reviewer (2011–present)
  • Expert Opinion on Drug Metabolism and Toxicology; Reviewer (2011–present)
  • World Journal of Clinical Oncology; Editorial Board Member (2010–2014)
  • Jackson Health System: Ad Hoc Committee on International Health Affairs; Committee Member (2010–2012)
  • University of Miami Sylvester Comprehensive Cancer Center: Director Search Committee; Committee Member (2010–2012)
  • University of Miami/Jackson Health System: Committee Task Force Annual Operating Agreement Committee; Committee Member (2010–2012)
  • University of Miami: Department of Molecular and Cellular Pharmacology Cardiac Section Faculty Search Committee; Committee Member (2010–2011)
  • Children's Oncology Group: Study Committee (ALTE11C2); Committee Member (2010–present)
  • Journal of Postgenomics: Drug & Biomarker Development – Open Access; Editorial Board Member (2010–present)
  • Nature Reviews Cardiology; Reviewer (2010–present)
  • University of Miami Miller School of Medicine: Pediatric Integrative Medicine Program; Director (2009–2014)
  • Miami CTSA Application: Scientific Advisory Board; Board Member (2009–2012)
  • UCare: Steering Committee; Committee Member (2009–2012)
  • University of Miami Medical Group: Finance Committee; Committee Member (2009–2012)
  • University of Miami Medical Group: Press-Ganey User Group; Member (2009–2012)
  • Miami CTSA Application: Research Resource Strategies Council; Member (2009–2012)
  • Research Education, Training and Career Development Component: Advisory Panel; Panel Member (2009–2012)
  • Miami Scholars Program: Miami CTSA Application; Chair (2009–2010)
  • Health and Environmental Sciences Institute: Cardiac Safety Technical Committee; Committee Member (2009–present)
  • HIV/AIDS – Research and Palliative Care; Editorial Board Member (2009–present)
  • Clinical Audit; Editorial Board Member (2009–present)
  • Adolescent Health, Medicine and Therapeutics; Editorial Board Member (2009–present)
  • Scientific Medicine; Editorial Board Member (2009–present)
  • Cancer Trials Support Unit: National Cancer Institute-Sponsored Phase III Cancer Treatment Trials; Member (2009–present)
  • University of Miami Sylvester Comprehensive Cancer Center: BioPsychoSocial Oncology Core; Member (2009–present)
  • Breast Cancer Research and Treatment; Reviewer (2009–present)
  • Clinical Cancer Research; Reviewer (2009–present)
  • University of Miami Miller School of Medicine: LCME Committee on Administration and Governance; Committee Member (2008–2012)
  • University of Miami Developmental Center for AIDS Research: Executive Committee; Committee Member (2008–2012)
  • Jackson Health System: Children’s Hospital Operations Oversight Standing Committee; Committee Member (2008–2012)
  • Jackson Memorial Hospital: Patient Safety and Risk Management Leadership Group; Member (2008–2012)
  • Association of Medical School Pediatric Department Chairs: Mentor’s Leadership Development Program for New Chairs; Member (2008–2012)
  • University of Miami/Jackson Memorial Hospital: Leadership Committee Group; Member (2008–2011)
  • American Society of Clinical Oncology: Educational Book Expert Panel; Panel Member (2008–2011)
  • International Journal of Pediatrics; Editorial Board Member (2008–present)
  • Transplants, Research and Risk Management; Editorial Board Member (2008–present)
  • Lymphoma and Chronic Lymphocytic Leukemias; Editorial Board Member (2008–present)
  • Pediatric Academic Societies: Pediatric Research Student Program; Member (2008–present)
  • Jackson Memorial Hospital: Miami Transplant Institute Transplant Emergency/Advisory Panel; Panel Member (2008–present)
  • Leukemia and Lymphoma; Reviewer (2008–present)
  • International Journal of Pediatrics; Reviewer (2008–present)
  • Future Cardiology; Reviewer (2008–present)
  • American Journal of Epidemiology; Reviewer (2008–present)
  • Acta Paediatrica (Stockholm, Sweden); Reviewer (2008–present)
  • Progress in Pediatric Cardiology; Associate Editor (2007–2014)
  • University of Miami Miller School of Medicine: NHLBI-Sponsored Training Program in Cardiovascular Signaling Faculty Member (2007–2013)
  • University of Miami Medical Group: Board of Governors Self-Insurance Committee; Committee Member (2007–2012)
  • University of Miami Developmental Center for AIDS Research: Internal Advisory Committee; Committee Member (2007–2012)
  • University of Miami Miller School of Medicine: Dean’s Executive Committee; Committee Member (2007–2012)
  • University of Miami Comprehensive AIDS Program: Executive Oversight Committee; Committee Member (2007–2012)
  • Miami Transplant Institute: Board of Governors; Member (2007–2012)
  • University of Miami Miller School of Medicine: Dean’s Quarterly Medical School Executive Group; Member (2007–2012)
  • Virology: Research and Treatment; Editorial Board Member (2007–present)
  • Journal of the American Medical Association; Reviewer (2007–present)
  • Annals of Internal Medicine; Reviewer (2007–present)
  • Expert Review of Cardiovascular Therapy; Reviewer (2007–present)
  • Cardiovascular Toxicology; Associate Editor (2006–2018)
  • Children of Chernobyl Relief and Development Fund: Medical Advisory Committee; Committee Member (2006–2014)
  • NHLBI: Pediatric Cardiomyopathy Registry and Pediatric Heart Transplant Study Group - Writing Committee; Co-Chair (2006–2013)
  • University of Miami Miller School of Medicine: Dean’s Operations Leadership Group; Member (2006–2012)
  • University of Miami Miller School of Medicine: Research Leadership Group Cabinet; Member (2006–present)
  • NICHD, NHLBI, NIAID, NIDA, NIMH, NIDCD: Pediatric HIV/AIDS Cohort Study - Adolescent Master Study Protocol Team; Member (2006–present)
  • NICHD, NHLBI, NIAID, NIDA, NIMH, NIDCD: Pediatric HIV/AIDS Cohort Study - SMARTT Study Protocol Team; Member (2006–present)
  • Journal of the National Cancer Institute; Reviewer (2006–present)
  • Children’s Cancer Research Fund: Grant Program; Reviewer (2006–present)
  • Biochemical Pharmacology; Reviewer (2006–present)
  • Canadian Medical Association Journal; Reviewer (2006–present)
  • Expert Review of Molecular Diagnostics; Reviewer (2006–present)
  • Congenital Heart Disease; Reviewer (2006–present)
  • Current Pharmaceutical Design; Reviewer (2006–present)
  • Jackson Health System: Fiscal Affairs, Purchasing and Budget Committee; Committee Member (2005–2011)
  • University of Miami Medical Group: Underwriting Committee; Committee Member (2005–2010)
  • NHLBI/Children's Cardiomyopathy Foundation: North American Pediatric Cardiomyopathy Biologic Specimen Repository - Board of Oversight; Chairman (2005–present)
  • Journal of Pediatric Hematology and Oncology; Reviewer (2005–present)
  • Cancer Chemotherapy and Pharmacology; Reviewer (2005–present)
  • Annals of Oncology; Reviewer (2005–present)
  • American Heart Association: Miami-Dade Division of the Florida/Puerto Rico Affiliate; Board of Directors (2004–2013)
  • University of Miami Miller School of Medicine: Micah Batchelor Child Health Research Grant Program; Chair (2004–2013)
  • Jackson Memorial Foundation: Golden Angel Society Physician Group; Member (2004–2013)
  • Jackson Memorial Medical Center: Clinical Practice Committee; Committee Member (2004–2012)
  • Cochrane Childhood Cancer Group Contributing Editor and Editorial Board Member (2004–present)
  • Cochrane Heart Group: Cochrane Library; Reviewer (2004–present)
  • Drug Design Reviews - Online; Reviewer (2004–present)
  • American Heart Journal; Reviewer (2004–present)
  • Cardiovascular Toxicology; Reviewer (2004–present)
  • Journal of Applied Physiology; Reviewer (2004–present)
  • Journal of AIDS; Reviewer (2004–present)
  • Cardiovascular Toxicology; Editorial Board Member (2003–2016)
  • Greater Miami Pediatric Society; Board of Directors (2003–2013)
  • University of Miami Medical Group: Governing Board; Board Member (2003–2012)
  • University of Miami Medical Group: Business Development and Strategic Committee; Committee Member (2003–2012)
  • Jackson Memorial Medical Center: Medical Executive Committee; Committee Member (2003–2012)
  • Florida Pediatric Society and Florida Chapter of American Academy of Pediatrics: Executive Committee and Chairs Committee; Committee Member (2003–2012)
  • University of Miami Medical Group: Executive Committee; Committee Member (2003–2012)
  • University of Miami Miller School of Medicine: Pediatric Executive Committee Meeting; Director (2003–2012)
  • University of Miami Miller School of Medicine: Pediatric Faculty Meeting; Director (2003–2012)
  • Jackson Memorial Medical Center: Clinical Chiefs-of-Service Meeting; Member (2003–2012)
  • University of Miami Miller School of Medicine: Clinical Chair‘s Group Meeting; Member (2003–2012)
  • Children’s Oncology Group: ALTE03N1 Study Committee; Committee Member (2003–present)
  • Florida Hospital Association: Florida Association of Children’s Hospitals; Member (2003–present)
  • Pediatric Blood and Cancer; Reviewer (2003–present)
  • Children’s Cardiomyopathy Foundation: Medical Advisory Board; Chairman (2002–present)
  • Archives of Disease in Childhood; Reviewer (2002–present)
  • Journal of Infectious Diseases; Reviewer (2002–present)
  • Journal of the Acquired Immune Deficiency Syndromes; Reviewer (2002–present)
  • FDA: Center for Drug Evaluation and Research – Animal Study Protocols Key Investigator (2001–2013)
  • Pediatric Cardiology; Reviewer (2001–present)
  • Pediatric Research; Reviewer (2001–present)
  • The Lancet; Reviewer (2001–present)
  • Acta Haematologica; Reviewer (2000–present)
  • Nature Medicine; Reviewer (1999–present)
  • NHLBI/NIH; Reviewer (1998–present)
  • Medical and Pediatric Oncology; Reviewer (1998–present)
  • Southern Medical Journal; Reviewer (1998–present)
  • Food and Drug Administration; Reviewer (1998–present)
  • Circulation; Reviewer (1997–present)
  • Journal of Noninvasive Electrocardiography; Reviewer (1997–present)
  • NHLBI: Pediatric Cardiomyopathy Registry - Steering Committee; Chairman (1996–present)
  • Dutch Cancer Society; Reviewer (1996–present)
  • Clinical Chemistry; Reviewer (1996–present)
  • Children’s Oncology Group Cardiology Investigator (1995–present)
  • NCI: Combination Chemotherapy and Radiation Therapy in Treating Children with Acute Lymphoblastic Leukemia Study Investigator (1995–present)
  • NCI: Treatment of Childhood Acute Lymphoblastic Leukemia Study Investigator (1995–present)
  • NHLBI: Pediatric Cardiomyopathy Registry Study Chair/Principal Investigator (1995–present)
  • Chest; Reviewer (1995–present)
  • American Journal of Physiology; Reviewer (1995–present)
  • International Journal of Cancer; Reviewer (1995–present)
  • Archives of Pediatrics and Adolescent Medicine; Reviewer (1994–present)
  • NIH/NHLBI: Pediatric Cardiac and Pulmonary Complications of HIV Infection Study – Cardiology Writing Committees; Chairman (1993–2010)
  • Journal of the American College of Cardiology; Reviewer (1993–present)
  • Cancer; Reviewer (1993–present)
  • Bone Marrow Transplantation; Reviewer (1992–present)
  • New England Journal of Medicine; Reviewer (1992–present)
  • Journal of Clinical Oncology; Reviewer (1992–present)
  • Medical Letter; Reviewer (1991–present)
  • Pediatrics (Journal of the American Academy of Pediatrics); Reviewer (1991–present)
  • Circulation Research; Reviewer (1991–present)
  • National Pediatric Cardiomyopathy Registry Principal Investigator (1990–present)
  • Journal of Pediatrics; Reviewer (1990–present)
  • American Journal of Cardiology; Reviewer (1990–present)
  • Progress in Pediatric Cardiology (1998, 2000, 2006-2008, 2010-2012, 2014-2018); Guest Editor

School News:

In the Media:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

UBMD Pediatrics
875 Ellicott Street
Suite 5018
Buffalo, New York 14203
Phone: (716) 881-7991
Fax: (716) 842-2100
slipshul@buffalo.edu
View map

Login to Update Your Profile